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Abstract 
The purpose of this project was to design a perfusion bioreactor to nourish the lumen of a 1 cm 
long 1.19mm inner diameter tissue tube comprised of rat smooth muscle cells in order to eliminate 
luminal cell necrosis.  The bioreactor maintained laminar flow through the lumen of the tube and a wall 
shear stress of 5-10 dynes/cm
2
.
  
After two prototypes were made, a final design was produced and tested.  
This design incorporated a chamber which could be connected to a flow loop along with a lid that could 
slide into the top of the chamber.  The lid was unique in that it had a hanging assembly for mounting the 
tissue tube, which was adjustable because one arm of the assembly moves along a magnetic track.  
Various proof-of-concept tests were performed to display the basic functionality of the device, including 
its ability to perfuse media through the lumen of a tissue tube and anchor a tissue tube in place.  More 
tests were performed to observe specific qualities of the bioreactor, such as its ability to avoid 
contamination and generate laminar luminal flow.  The final test performed involved mounting a 19-day 
old tissue tube inside the bioreactor and running the bioreactor for 3 days inside an incubator.  Tissue 
tubes from the same batch were left growing in static culture on silicone mandrels, and tissue tubes 
cultured statically for 19 days served as additional control tissues for histology.  This way, the size and 
morphology of tissue tube cultured in the bioreactor could be compared to tissue tubes prior to incubation 
and also to tissue tubes which were not mounted in the bioreactor.  It was ultimately concluded that the 
bioreactor successfully minimized cell necrosis near the luminal surface, as there was a lack of 
fragmented nuclei in the bioreactor-cultured sample compared to the statically-cultured sample. 
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Chapter 1: Introduction 
 Tissue engineered blood vessels could be one of the next great developments in modern medicine.  
However, tissue engineering as a science is still in its developing stages and there are a variety of ways to 
grow tissue tubes to mimic blood vessels.  For example, Professor Marsha Rolle's laboratory team 
produces tissue tubes by culturing rat smooth muscle cells on silicone tubing mandrels.  Unfortunately, a 
problem has been noted with this method.  The inside of the tubes contact silicone tubing mandrels, 
therefore the inner cell layers do not receive the same access to nutrients as the outer layers when they are 
submerged in cell culture medium.  Because of this, there is non-uniform growth in the tube; the outer 
layers grow faster than the inner layers.  If the tubes grow thick enough, the inner layers suffer cell death 
due to a lack of nutrients. 
 A means of solving this problem would be to pump media through the inside of the tube, called 
the lumen, in order to both nourish the cells and keep the tissue tube open after the mandrel is removed.  
This would require the use of a perfusion bioreactor.  Bioreactors are devices which house tissue, 
nourish it, and promote its growth in a simulated physiological environment.  A perfusion bioreactor 
accommodates hollow regions within a specific tissue structure, such as the pores of bone tissue or the 
lumen of a blood vessel, by flowing media through these regions. 
 Due to the qualities of the tissue tubes in question, a custom perfusion bioreactor needed to be 
made.  The tubes are very fragile and small, 1 cm in length and 1.19 mm in diameter.  Such a small size 
makes it challenging to mount the tubes into available bioreactors.  Flow through the lumen needed to be 
very slow due to this size, so as to not put unnecessary stress on the tubes.  In addition, fluid flow 
needed to be laminar, meaning that the flow would move through the tube in a straight path without 
turbulence, also to prevent excessive stress on the tube walls. 
 Our group's project progressed as follows.  First, we focused on gaining a better understanding 
of the physiological parameters of blood vessels as well as the unique features of the tissue tubes we 
would be working with.  We then decided on a list of constraints as well as objectives we needed to 
meet.  Second, we researched existing perfusion bioreactors and decided which ideas and features could 
be borrowed from these designs and incorporated into our own. Third, we focused on coming up with 
original ideas to deal with the unique problems we faced to create an easy to use, leak-free perfusion 
bioreactor that was as effective, if not more, than existing means.  Finally, we produced and tested a 
prototype to determine whether or not it satisfied all constraints, while taking into consideration how well 
it met objectives.  From here, minor alterations were made and the final product was assembled. 
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 The paper summarizes the literature we reviewed on physiological parameters of blood vessels, as 
well as existing bioreactors.  Next, we discuss our progression through the design process, outlining 
design alternatives and the reasons specific choices were made.  The last sections deal with tests of our 
prototype and final design along with the final conclusions our group has made regarding the outcome of 
our project. 
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Chapter 2: Literature Review 
 The following chapter will introduce the reader to the problem our project is trying to overcome. 
Vascular physiology, tissue engineering, bioreactors, and the current methods being used in the field will 
be discussed.  
2.1 Vascular Physiology 
 An understanding of normal physiology is necessary to design an environment which mimics the 
conditions inside a natural blood vessel. Physiological parameters in normal individuals will be discussed 
as well as the diseases affecting blood vessels and current treatment. It is important to understand how the 
body works in a physiological state when trying to recreate those parameters in a bioreactor.  
2.1.1 Physiological Parameters 
 Normal blood pressure is about 120/80 mm Hg. Blood flow through a vessel depends upon the 
viscosity of blood (η), the pressure gradient (Pi-Po), and the radius of the vessel (r), all of which can vary 
depending upon the location of the vessel. Flow (Q) can be determined by the following equation: 
   
 (     ) 
 
   
 
The viscosity of blood depends on the diameter of the tube it is flowing through, shear rate or velocity, 
hematocrit, and temperature (Khurana, 2006). Viscosity decreases as the flow rate increases due to shear 
thinning (Koeppen & Stanton, 2010). The viscosity of blood at 37°C is 2.8-3 centipose (mPa/s) (Khurana, 
2006) which converts to 7.5 x 10
-6
 mmHg/second.  The relative viscosity of blood (when compared to 
water at 5.2 x 10
-6
 mmHg/second) can vary between about 2 and 4.6 when tube diameter is smaller than 
500µm (D'Ancona, Ricci, & Bergsland, 2001). 
The velocity of blood running through a blood vessel can be calculated by v=Q/A, where v is 
velocity, Q is flow rate, and A is cross sectional area. Typical resting blood flow rates are about 68 
mL/min in the carotid artery and can increase to about 300 mL/min during exercise (Carnagey et al., 
2003).  
Flow of a fluid can be described as either laminar or turbulent. In laminar flow, shown in Figure 
1, particles at the center of the vessel have the highest velocity while those against the walls have almost 
no velocity. Laminar flow occurs when particles travel parallel to the vessel walls (Noble, 2005). Laminar 
fluid flow reduces friction between layers of cells in the blood and the blood cells and platelets travel at 
the center of the vessel (Hannon, Pooler, & Mattson Porth, 2009). Higher energy and pressure is needed 
to propel turbulent flow (Hannon, Pooler, & Mattson Porth, 2009). Turbulence occurs at critical velocity 
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(Noble, 2005) and can be caused by increased velocity, change in diameter, or a change in blood viscosity 
(Hannon, Pooler, & Mattson Porth, 2009). Turbulence is characterized by random flow of particles caused 
by the breaking up of the fluid layers (Bell & Rhoades, 2008). Turbulent flow can damage the endothelial 
lining of blood vessels, leading to atherosclerotic plaques (Noble, 2005) which can cause blood clots 
(Hannon, Pooler, & Mattson Porth, 2009). A Reynolds number under 2100 corresponds to laminar flow 
(Munson et al., 2009). The Reynolds number can be calculated for each flow rate with the following 
equation, where ρ is density of the fluid, V is the mean velocity, r is tube radius, and µ is the viscosity of 
the fluid: 
 
 
Figure 1: Schematic of a laminar flow profile. Particles flow parallel to the vessel walls and those in the center of the 
vessel have a higher velocity. 
 
Blood vessels are exposed to a hemodynamic force called shear stress. Shear stress plays a critical 
role in the function of blood vessels. Shear stress protects vessels from atherosclerosis by increasing the 
production of prostacyclin, a substance that increases vasodilation and decreases platelet aggregation 
(Waksman, Serruys, & Schaar, 2007). It also does this by releasing tissue plasminogen activator and nitric 
oxide. Thus, vessels with low shear stress are more likely to have atherosclerosis and intimal lesions. 
High shear stress can cause damage to vascular smooth muscle cells because the nitric oxide levels can 
become too high and activate Fas which initiates apoptosis (Waksman, Serruys, & Schaar, 2007). Shear 
stress can also alter endothelial cell alignment as well as their proliferation and migration (Ascher & 
Haimovici, 2004). The average range of shear stress in normal blood vessels has been found to be 
between 10 and 15 dynes/cm
2
 (Aird, 2007). Shear stress can be calculated by the following equation: 
 
Where  is the viscosity of the fluid, Q is the flow rate, and r is the radius of the tube (Reneman, 2006).
 
3
4
r
Q


 
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2.1.2 Blood Vessels 
The primary function of blood vessels is to carry oxygenated blood from the heart to the rest of 
the body as well as return the deoxygenated blood to the heart. Three major types of blood vessels exist: 
arteries, veins, and capillaries. The main function of arteries is to carry blood from the heart and deliver 
oxygen to the body cells. Veins return the oxygen-deprived blood to the lungs via the heart so that the 
blood can be re-oxygenated and reused. Capillary beds supply blood to organs and tissues. Arteries and 
veins are cylindrical in shape and have multiple layers, as seen in Figure 2. The blood containing space in 
the center of the vessel is referred to as the lumen. The innermost layer, the tunica intima, is a layer of 
connective tissue lined with endothelial cells that produces substances to regulate vasoactivity, blood 
clotting, inflammation, and vascular growth.   The middle layer, or the tunica media, is composed of 
smooth muscle cells and elastin. The cellular agents found in this layer cause vasoconstriction and 
vasodilation, the muscular movements that affect blood flow.  The final layer, the tunica adventitia, 
structurally supports the vessel with collagen fibers and by anchoring the vessels to other structures 
(Marieb & Hoehn, 2006). 
 
Figure 2: The layers of a blood vessel. Blood vessel is shown transversely. 
 
2.1.3 Diseases and Current Treatments 
 Cardiovascular disease is the leading cause of death in the United States (Roger et al., 2011).  
Tissue engineering holds promise for new advances in the treatment of cardiovascular disease.  For 
example, coronary bypass surgery currently uses the saphenous vein in the leg, mammary artery in the 
chest, or the radial artery in the arm to bypass the blockage (Bhimji, 2010).  Tissue engineered blood 
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vessels could make coronary bypass surgery simpler (Mitchell and Niklason, 2003) by removing the step 
of retrieving an autologous graft or skipping the process of finding a donor.  The primary disadvantage to 
using transplanted arteries is the extraction process.  The patient must undergo surgery to extract the 
artery as well as the bypass surgery, increasing the chance of complications.   Luckily, advancements in 
tissue-engineered blood vessels could be the key to increasing the success rate of this procedure by 
making artery extraction unnecessary (L’Heureux et al.,2007). 
2.2 Current Tissue Engineering Methods 
 The following sections discuss different methods for engineering vascular tissues.  
2.2.1 Scaffolds 
In order to develop tissue engineered blood vessels, there needs to be a structure for seeding cells.  
Scaffolds provide support and promote cell adhesion and proliferation.  There are many natural and 
synthetic materials used to make scaffolds which can be permanent or biodegradable (Baguneid et al., 
2006).  
Synthetic scaffolds can be made from various non-biodegradable polymers such as polyester 
urethane, polyurethane, Dacron, and poly(carbonate–urea)urethane(Baguneid et al., 2006).  The non-
biodegradable polymers can be coated with collagen to mimic the extracellular matrix to allow 
endothelial cells and smooth muscle cells to grow on the surface (Baguneid et al., 2006).   Furthermore, 
bio-degradable polymers can be used in blood vessel scaffolds. PGA and polyhydroxyalkanoate (PHA) 
are most widely used for this application because smooth muscle cells can be seeded onto these bio-
degradable scaffolds and over time take the place of the polymer molecules to create a 3D tissue construct 
(Baguneid et al., 2006). PCL is also used in this application in PCL-PLA scaffolds (Shin’oka, 2004). 
Examples of materials used as natural scaffolds include collagen (Baguneidet al., 2006), silk 
(Lovett et al., 2007), fibrin, and hyaluronan (Burdick, 2010). Collagen is a good candidate because it is 
abundant in the body and present in the extracellular matrix (Baguneid et al., 2006). Collagen also 
promotes cell adhesion, growth, and differentiation and is commonly used in scaffolds for these properties 
as well as its structural properties (Burdick, 2010). Fibrin is made from fibrinogen and thrombin which 
are found in blood plasma. Fibrin is involved with blood clotting, inflammation, and wound healing and 
promotes angiogenesis, cell adhesion, and cell proliferation (Burdick, 2010). Hyaluronan (HA) is a major 
component of the extracellular matrix and plays a role in cell proliferation, adhesion, motility, and 
morphogenesis. Scaffolds made from HA are very biocompatible and flexible (Burdick, 2010).  
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Decellularized tissue can also be used as scaffolds. These structures consist of the extracellular 
matrix (ECM) of the original source.  These scaffolds can be derived from sources in the body such as 
human umbilical cord veins and small intestine submucosa or from xenografts like a porcine aorta which 
can then be seeded with human cells (Baguneid et al., 2006). Decellularized tissue is often used as 
scaffolds because they promote stem cell differentiation due to biochemical cues from the ECM and 
because they provide the geometry of the structure being engineered (Burdick, 2010).  
2.2.2 Cell Sheet Method 
 L’Heureux et al. (1998) developed a new way to grow tissue engineered blood vessels.  This 
method is referred to as the ―Cell Sheet Method‖ and involves culturing smooth muscle cells with 
fibroblasts in a tissue culture flask.  After thirty days, the cells formed sheets which were then removed 
from the flask and rolled around a mandrel.  Cell adhesion resulted in the formation of a tubular 
structure. This method proved to be a breakthrough in tissue engineering because the tissue tube did not 
require a synthetic scaffold like previous tissue engineered blood vessels. 
2.3 Cell Culture Method Used in Professor Rolle's Lab 
 There are many different ways tissue engineered blood vessels can be made.  For our project, we 
will be working with tissue engineered blood vessels that are grown using a similar method that Kshama 
Doshi (2009) developed in Professor Marsha Rolle's lab. This method is similar to the scaffold method 
because a silicone mandrel is used to assist in the growth and shape of the tissue tubes.  However, the 
final result is a tube made predominantly from cells and cell-derived matrix, without exogenous scaffolds. 
 First, a silicone mandrel is prepared.  The silicone mandrel's purpose is to provide a support 
structure for cell seeding and growth.  The cells grow and adhere around the mandrel resulting in a 
tubular structure.  Doshi (2009) used collagen-coated silicone mandrels in her experiments to facilitate 
cell adhesion, whereas plasma-etched silicone mandrels were used in subsequent experiments and for our 
project.  The cell seeding process requires the construction of a cell seeding ring, which is made of 
polydimethylsiloxane (Doshi, 2009). The cell seeding ring has two grooves in it so the mandrel can fit 
into it and be glued in place.  Next, the smooth muscle cells are pipetted into the middle of the cell 
seeding ring.  The culture dishes are then inverted and placed in an incubator at body temperature (37°C) 
for thirty minutes (Doshi, 2009).This procedure is referred to as that hanging drop method (Figure 3).  
After the thirty minutes have passed, the samples are rinsed twice with buffer solution to remove any 
unattached cells. Next each well is filled with 6 mL of fresh cell culture media. The cells continue to grow 
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in culture for approximately twenty to twenty-eight days. The silicone mandrel is then removed using 
forceps.  
 
Figure 3: Schematic from Doshi (2009) of the hanging drop cell seeding method. A: Top view photograph and side view 
schematic of the final cell seeding assembly. B: RASMC cell suspension pipetted into the center of the seeding assembly. 
In the last step, the seeding assembly is flipped upside-down 
 
 After evaluating the tissue growth, Doshi noticed that cells at the inner layer of the tube that was 
closest to the mandrel appeared necrotic.  The cell density on the inside was far less than that of the 
outside, which had been in direct contact with the media (Doshi, 2009).  It was concluded that the inner 
layer was poorly nourished due to its positioning beneath the other layers and adjacent to the silicone 
mandrel, which prevented exposure to the media. 
2.4 Our Project 
 Our MQP was developed to produce a perfusion bioreactor which could grow the tissue tubes 
while preventing necrosis of the inner cells by the lumen.  Our group will be removing the silicone 
mandrel between the twentieth and twenty-eighth day of culture. By introducing flow through the lumen 
of the tissue tube during cultivation, necrosis should be prevented while keeping the tube from collapsing 
shut. 
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2.5 Bioreactors 
Bioreactors are devices used to cultivate tissues and simulate an in vivo environment.  Most 
bioreactors are designed with a specific tissue type in mind, so that exact physiological environment for 
the singular tissue type can be fabricated.  In the case of this project, vascular tissue is the focus. 
2.5.1 Cell Culture Media 
Bioreactors typically contain cell culture medium, an aqueous solution containing nutrients 
required for cell growth.  In addition to serum, the media often contains a pH buffer, antibiotics, amino 
acids, and glucose.   
2.5.2 Perfusion in Bioreactors 
 In this project, perfusion must be maintained through the lumen of the artery.  The most common 
means of doing this is to use a pumping system to directly flow media through the lumen.  There are 
several creative methods of producing perfusion in existing bioreactors.  For instance, gravity and fluid 
dynamics along with some applied force on the bioreactor module can create flow and mixing of the 
media (Baguneid et al., 2006).  The most common choices of pumping mechanisms are syringe pumps 
and peristaltic pumps.  Williams and Wick (2005) created a design which used a pair of syringe pumps to 
provide perfusion while a peristaltic pump produced external flow to circulate the media for the outer cell 
layers. 
2.5.3 Anchoring Methods 
 With the presence of fluid flow around and within a tissue, a method of anchoring the tissue in 
place becomes a necessity.  Ultimately the goal of anchoring the tissue is to secure it within the chamber 
while making as little physical contact with the tissue as possible.  If too much surface area is covered by 
an anchoring structure, the cells in that area may not receive proper nutrition and oxygenation.  Zhang et 
al. (2009) anchored their cell tube with O-rings at each end.  Williams and Wick (2005) anchored their 
cell tubes by simply mounting both ends onto parallel syringe needles and suturing. 
2.5.4 Gas Exchange 
 Providing the cells of tissue engineered blood vessels with the proper nutrients is important and 
can be achieved by flowing media through and around the constructs. However, the cells need to receive 
oxygen and expel CO2. Gas exchange occurs naturally in the body in the pulmonary capillary beds 
(Koeppen & Stanton, 2010).When air comes into contact with media, oxygen can diffuse into the media 
and CO2 can diffuse out. Gas exchange can be achieved by peroxide-cured silicone tubing (Zhang et al., 
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2009), a gas exchange unit (Iwasaki et al., 2008), or leaving an opening (with a semipermeable membrane 
or filter) so gas can diffuse in and out (Webb et al., 2007). 
2.5.5 Specific Designs 
Webb et al. (2007) designed a bioreactor for small-diameter tissue engineered blood vessels. The 
bioreactor consisted of a media reservoir, a peristaltic pump, a compliance chamber, a growth cassette, 
tubing, and a series of components to regulate the pressure in the media reservoirs. Air pressure was 
controlled (and maintained at a constant level) by a gas regulator and compressed air tank and valves 
were controlled via LabVIEW. The compliance chamber was put in place to reduce the pulsatile fluid 
flow from the pump so that only the pressure from the pump was being used (this was mainly for 
mechanical conditioning). The transparent growth cassette (Figure 4) was needed to measure vessel 
growth by LED micrometer, but also provided a housing unit for the vessel and could be removed easily 
from the circuit. The growth cassette provided a water-tight chamber made from rubber gaskets, thumb 
screws, and an aluminum frame. Vessels were secured in the cassette by male Luer connectors. 
Additional Luer connectors were put in the growth cassette to allow for gas exchange between the media 
and the air inside the incubator and were also used as inlets and outlets for media change. 
 
 
Figure 4: Growth cassette developed by Webb et al. (2007) which includes the cassette body (A), plexiglass faceplate (B), 
rubber gasket (C), aluminum frame (D), flow inlet/outlets via Luer connectors (E), Luer connector for scaffold 
attachment (F), and an air filter for gas exchange attached to a Luer connector (G). 
 
The construction of the cassette provided a leak-free system and a clear viewing window of the 
sample; however, the assembly appears to be tedious to assemble due to the frames and screws. It may 
take time to break down and reassemble the cassette each time the tissue samples were inserted or 
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removed. The cassette is compact and a convenient way to move the tissue sample. It is also very 
adaptable because the cassette can be attached to a wide range of pumps or other machines.  
Gas exchange through the Luer connectors and filters is a good alternative to the semipermeable 
silicone tubing. An additional attachment may be needed so that the tube does not slip off or leak, a 
feature that was not mentioned in the paper. It was not mentioned how the tube attached to the Luer 
connectors.  
Neumann, Nicholson, and Sanders (2003) created a perfusion bioreactor for tissue engineered 
blood vessels by seeding vascular smooth muscle cells onto nylon fibers. These vessels were very small 
in size at about 100 microns in diameter and not designed as vascular grafts. Shrink tubing was used in 
order to hold the nylon fibers in place. The culture chamber was made from polycarbonate sheets and 
grooves were made to insert the shrink tubing and nylon. The whole bioreactor was put into a cell-
suspended culture medium in order for the cells to adhere onto the nylon. After culture, the vessel 
chamber was filled with agar and the nylon fibers were gently pulled out of the bioreactor. The bioreactor 
outlet was connected to a peristaltic pump set to pump media through at 2 mL/hour. Gas exchange was 
achieved by an aerated culture flask used as a media reservoir. This feature compromises portability and 
also requires a volume of 25 mL of media.  
This bioreactor was successful in creating very small blood vessels but the nylon/shrink tubing of 
the bioreactor must be replaced after each procedure. The materials are inexpensive and it has been shown 
that the nylon lines come out easily without disrupting the tissue tubes. With the use of shrink tubing, the 
need to find a way to attach the tissue tubes to the perfusion system is eliminated. The tissue is not being 
pinched or punctured in any way and the whole length of the tube is receiving nutrients. By filling the 
chamber with agar, the vessels were physically protected and received nutrients. It is unclear whether or 
not this method is advantageous with regards to nutrient delivery, but it clearly stabilizes the small tubes. 
Zhang et al. (2009) developed a bioreactor that could grow and condition artificial silk-based 
vascular grafts.  The bioreactor had both an external and internal closed perfusion loop through the 
lumen and the outside the tissue respectively, as seen in Figure 5. The polycarbonate perfusion chamber 
was transparent for observation.  The chamber was watertight to prevent media loss and contamination.  
Each end of the graft was secured with a pair of O-rings.  Pulsatile flow was conducted by a peristaltic 
pump.  Gas exchange was achieved through peroxide-cured silicone tubing. 
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Figure 5: Bioreactor made by Zhang et al. (2009).  Labeled are (A) luminal inlet, (B) luminal outlet, (C) external media 
inlet, (D) external media outlet, (E) silk-based vascular graft, and (F) the O-rings which hold the graft in place. 
 
Williams and Wick (2005) created a bioreactor to co-culture smooth muscle cells and endothelial 
cells to simulate the structure of blood vessels. This design has two methods of pumping, one for luminal 
flow and one for external flow.  Luminal flow is produced by dual syringe pumps, which the tissue tube 
is sutured between.  Meanwhile, in a perpendicular direction, a peristaltic pump flows media externally.  
It is unclear how the media was kept oxygenated. 
 The simplistic design of the chamber allows for repeating units, meaning several tissue tubes can 
be grown at the same time by a single peristaltic pump, although it would still necessitate additional 
syringe pumps since the chambers cannot share luminal flow.  To improve the design, a multichannel 
peristaltic pump could be incorporated to pump media both luminally and externally in order to cut costs.   
Lovett et al. (2007) created a bioreactor that could culture tissue microtubes. The main structure 
of the bioreactor is composed of a 25mm  60 mm  5mm PDMS block, a glass cover slip bonded 
together using vacuum gas plasma, and a glass cover top attached using label tape. Three 10mm  15mm 
 5mm wells exist within the PDMS block to form the bioreactor space. Perfusion of fluid through the 
lumen of the tubes is achieved by running stainless steel needles through each bioreactor.  The 
microtubes span the length of the steel needles in the bioreactor.  An external syringe pump was used to 
provide the pressure to perfuse the bioreactor with media.  
The reactor’s small size allows it to be portable. One disadvantage is that media in the well is 
stagnant.  Another disadvantage is that the small volume of each individual well may require media to be 
changed frequently. Figure 6 illustrates the design of the bioreactor. 
24 
 
 
 
 
Figure 6: Top View Bioreactor Schematic of the design by Lovett et al.(2007). Labeled are the PDMS block (A), the 
media-filled wells (B), steel needles for perfusion (C), and the tissue tube mounted on the needles (D). 
 
Another example of a bioreactor that has produced viable vessel cultures is that of De Maria et al. 
(2007). The main components of the bioreactor system were a vessel culture chamber, a peristaltic pump, 
and a mixing chamber. The vessel culture chamber is PDMS casted with a top and a bottom portion, as 
displayed in Figure 7.  Silicone tubes connected to the perfusion system are inserted through the top 
portion and sealed.  The bottom portion creates a larger volume for the chamber and locks with the top 
to create an airtight seal. A peristaltic pump allowed perfusion of media through the silicone tubes.  
Laminar flow of the system was validated by calculating the Reynolds number of the system. The mixing 
chamber acts as a media reservoir and also contains feedback sensors for the temperature, pH, oxygen and 
CO2 levels, and flow of the media.  
The advantages of using this system are that the bioreactor uses little media and is made of low-
cost PDMS and aluminum.  Although the volume and dimensions of the device were not specified, the 
size of the chamber accommodated vessels that were 1cm long and .2cm wide. Based on the size of the 
tube and the scale used in Figure 7, the volume of media necessary to submerge the tissue appears 
minimal.  Sensors also give information about the media that can be used to alter the system to emulate 
different physiological conditions.  
 A 
 B 
C 
D 
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Figure 7: The vessel culture chamber of De Maria et al.'s (2007) design.  The top of the chamber (A) and the bottom of 
the chamber (B) assemble together and the inlet connectors (C) allow for perfusion through the tissue tube (D). 
 
 These bioreactors all have design aspects that allow successful tissue tube nourishment.  A major 
distinction between the types of perfusion bioreactors is the number of flow loops, which is generally 
either one or two.  The design by Williams and Wick uses two flow loops to nourish both the lumen and 
the exterior of the tubes.  De Maria et al. and Lovett et al. perfuse media through the lumen of the tubes 
while having the rest of the tissue remain in static culture. Ideally we would like to produce a bioreactor 
that could dynamically culture the exterior of a tissue tube along with the inside, but at the same time our 
budget would make having two pumps difficult.   
Familiarizing ourselves with these bioreactors, along with various tissue engineering methods, 
helped us formulate a good idea of what our bioreactor should do and what features it should have.  
Based on the objectives of our project, our design needed to be able to house a tissue tube and perfuse cell 
media through its lumen while providing gas exchange.  Ideally the device would be as safe as possible 
for the tissue tube while being simple to use and inexpensive. 
  
A 
 
 B 
C 
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Chapter 3: Project Strategy 
After meeting with Professor Rolle and Zoe Reidinger, our clients, we were able to acquire a 
better understanding of the goals of our project.  We then underwent extensive background research to 
familiarize ourselves with bioreactors.  Other areas of research included physiological parameters of 
blood vessels, cardiovascular physiology and problems, and alternate tissue engineering methods to grow 
arteries. To help us determine which direction our project was heading, we had to determine the 
objectives, constraints, and functions of our perfusion bioreactor. We used several design tools such as 
client interviews to clarify the objectives, constraints, and functions, a pairwise comparison chart, and a 
morphological chart. 
3.1 Initial Client Statement 
 Our initial client statement given by Professor Rolle was, ―The goal of this project is to create a 
cartridge to house a tissue engineered blood vessel that securely anchors the tissue sample without 
damage or leaking, and can be connected to both a luminal flow system and an external medium flow 
loop to provide continuous nutrient supply to the tissue and apply physiological shear stresses at the inner 
surface of the vessel.  Ideally, the cartridge should be inexpensive and easy to manufacture, such that 
multiple cartridges can be used in a single experiment to culture batches of tissue engineered blood 
vessels.  Finally, the cartridge should be interchangeable with the mechanical conditioning cartridge 
under development by another MQP team and members of the Rolle Laboratory." 
3.2 Objectives 
 In order to better understand the task at hand, we had to determine the wants of the client.  We 
made a list of objectives that our client wanted to be present in the design and they are ranked by 
importance based on the summary chart of our pairwise comparison chart seen in Table 1. 
 Easy to sterilize and clean  
 Control flow of media 
 Maintain laminar flow  
 Durable 
 Easy to make 
 Easy to use  
 Portable 
 Interchangeable cartridge 
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 Inexpensive 
 Adjustable (able to fit different sized tissue tubes) 
 
The perfusion bioreactor is in direct contact with living cells; therefore, all of the components must be 
easy to sterilize and clean.  The tissue tubes being used in this project are not made using scaffolds. 
Without a physical object, or constant fluid perfusion, holding the lumen open, the tissues are prone to 
collapse and ingrowth. The perfusion bioreactor should be able to withstand everyday use.  The device 
should be easy to manufacture and assemble with regards to the availability of parts.  Our design should 
be easy to use so that few instructions are needed to operate it.  The fewer components the device has, 
the cheaper and more durable it will be. The interchangeable cartridge should fit in our perfusion 
bioreactor as well as the mechanical conditioning device and be easily portable.  The parts should be 
relatively cheap so they can be replaced.  Lastly, the device could potentially be able to accommodate 
multiple sample sizes.  In order to organize and rank these objectives, we constructed a pairwise 
comparison chart and the summary is shown in Table 1. 
 
Table 1: The summary of the results from our Pairwise Comparison Chart.  High numbers correspond to objectives with 
the most importance. 
Rank Goal Total 
1 Ease of Sterilization 9 
2 Control Flow of Media 8 
3 Maintain Laminar Flow 7 
4 Durable 5.5 
5 Easy To Make 4.5 
6 Easy to Use 4 
7 Portable 4 
8 Interchangeable 2 
9 Adjustable 1 
10 Inexpensive 1 
 
 The results of our pairwise comparison chart showed that the clients find ease of sterility the most 
important.  While sterility is a constraint, our goal is to make sterilization as easy as possible by reducing 
the steps that are required.  The clients wanted to be able to control the flow of the media and for the 
device to maintain laminar flow. Other important factors turned out to be durability, easy to manufacture, 
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portability, and easy to use. The clients did not feel that price was as important an issue.  Other 
objectives given the least priority were making the device adjustable for different size tubes or 
interchangeable with other devices.  
3.3 Constraints 
 Our group has several constraints to meet.  If our project does not meet a constraint, the project 
as a whole will be a failure.  These constraints include: 
 Device Must Maintain Sterility During Cultivation 
 Time (the A-D term deadline) 
 Budget of $524 
 No Leaking 
 Size (must fit in the incubator) 
 Mechanically Safe for Tissue Tube (no ripping) 
 Safety for User 
 Our group is working with living tissue so the materials we use to construct the perfusion 
bioreactor must be able to be kept sterile. The project must be completed before Project Presentation Day 
on April 21, 2011. Our team budget consists of $524. The perfusion bioreactor cannot leak media. The 
perfusion bioreactor must fit in an allotted incubator which is approximately nine inches high.  In order 
for our device to be successful, it must be safe physically and biologically for the tissue tube.  Most 
importantly, the device must be safe for its users.  There should not be any sharp edges or dangerous 
components that are exposed. 
3.4 Functions 
 Once we established the objectives and constraints, we had to determine what functions our 
perfusion bioreactor actually had to perform.  We concluded that our perfusion bioreactor had to: 
 Supply Media Through the Lumen in Order to Nourish the Tissue Tube 
 Anchor the Tissue Tube 
 Fill Cell-Holding Chamber with Media 
 Empty Used Media 
 Permit Gas Exchange 
 
The primary function that is mentioned in the client statement is pumping media through the 
lumen of the tissue.  According to Zoe Reidinger, the tissue tube has to be fed from the inside to reduce 
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the cell death that was observed after culturing tissue tubes on silicone mandrels for 14 days.   Our 
device also has to anchor the tissue while the media is being pumped through the lumen.  Lastly, our 
perfusion bioreactor must enable gas exchange to maintain oxygenation and buffering of the cell culture 
medium. 
3.5 Specifications 
 The tissue tube sample we used was 1cm in length and had an inner diameter of 1.19mm. Based 
upon the information Zoe gave us, the tissue tubes required 6mL of media exchanged every four days.  
Our perfusion bioreactor contained enough media for a three day period which is a minimum of 4.5mL.  
This number was calculated by assuming a linear relationship. 
Wall shear stress is a tangential stress applied to vessel walls when blood is flowing through the 
vessel and has been found to affect cell function, shape, and gene expression in blood vessels (Reneman, 
2006). Typically in a human blood vessel shear stress ranges between 10 and 15 dynes/cm
2
 (Aird, 2007), 
however, our client requested a range of 5-10 dynes/cm
2
.By putting the minimum and maximum shear 
stress values (5 and 10 dynes/cm
2
) into the wall shear stress equation found in section 2.1.1, we were able 
to calculate the appropriate range of flow rates of 7.16 to 14.3 mL per minute. 
 We needed to know if the appropriate flow rates were laminar in order to abide by our laminar 
flow constraint. The data in Table2 shows the velocity, flow rate, and Reynolds numbers (Re) within the 
required shear stress range. In order to meet our specification, we used a flow rate between 4.4 and 
8.8mL/min. As seen below, all of the flow rates in this range are laminar because Re< 2100.  
 
Table2: Velocity, flow rate, and Reynolds number for wall shear stresses between 5 and 10 dynes/cm2. 
Pump 
Flow Rate 
(mL/min) 
Fluid 
Velocity 
(cm/s) 
Calculated 
Wall Shear Stress 
(dynes/cm
2
) 
Calculated 
Reynolds 
No. (Re)  
7.16 10.7 5.00 183 
8.00 12.0 5.59 204 
9.00 13.5 6.29 230 
10.0 15.0 6.98 255 
11.0 16.5 7.68 281 
12.0 18.0 8.38 306 
13.0 19.5 9.08 332 
14.0 21.0 9.78 357 
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14.3 21.5 10.0 365 
 
 In order to reduce the amount of media required to fill our bioreactor, we tried to make it as small 
as possible while still performing the needed functions.  The dimensions of the lid are 5 inches by 2.5 
inches with a thickness of 0.5 inches. The chamber is 4 inches by 1.65 inches with a height of 0.88 inches. 
The chamber can hold 26 mL of cell media.  To recapitulate our specifications: 
 Tube dimensions: 1 cm long, 1.19 mm inner diameter 
 Bioreactor chamber dimensions: 4" x 1.65" x 0.88" 
 Media reservoir volume: 26 mL 
 Pump flow rate: 8.33 mL/min 
 Calculated shear stress: 5.65 dynes/cm2 
 Calculated Re: 185 
3.5 Revised Client Statement 
After clarifying our objectives, constraints, and functions, we were able to develop a revised 
client statement that focused on the main goals of the project. The goal of our project is to construct a 
bioreactor that will simulate an in vivo environment for tissue-engineered blood vessels. The bioreactor 
will deliver nutrients to the lumen of the engineered blood vessel via laminar flow and provide 
nourishment for the cells at the outer edge of the vessel.  It will contain enough media to sustain the 
tissue tube for three days.  The bioreactor must not leak or cause the tissue to tear. The overall design 
should also be easy and inexpensive to make and intuitive to use. 
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Chapter 4: Design Alternatives 
After defining our functions, we developed a morphological chart (seen in Table 3) to examine 
the different combinations of means to meet the functions.  Each function and mean is discussed in the 
sections below.  We ranked the morphological chart based on our prioritized objectives and feasibility. 
 
Table 3: Morphological chart depicting the functions and means to fulfill those functions. Each mean is ranked by 
feasibility; 1 being the most feasible. 
 
4.1 Design Components 
 This section discusses the means considered to fulfill each function.  Their advantages and 
disadvantages are explained. 
4.1.1Nourish Tissue/ Media Flow 
As previously mentioned, the perfusion bioreactor must provide media flow through the lumen of 
the tissue tube to prevent cell death and keep the lumen open. The peristaltic pump is widely used in 
perfusion bioreactors. Peristaltic pumps can power single or multiple flow loops and can be adjusted to an 
appropriate speed. One of the original ideas we had when deciding on a pumping mechanism was a fish 
tank pump.  This variety of pump uses a small water wheel to propel fluids. Generally fish tank pumps 
are very cheap, but their flow rates are non-adjustable. 
There are means of perfusion other than pumps.  The rocking method involves a media chamber 
rocking back and forth to mix the media.  This method is generally used when the sample is a 2D 
scaffold rather than a 3D construct.  In addition, the rocking method is not suitable for our project 
because it would likely result in turbulent flow.  Turbulent flow could cause damage to the cells and the 
Functions
Nourish 
Tissue/Media 
Flow
3.) rocking 4.) vertical flip 2.) fish tank pump
1.) peristaltic 
pump
5.)intake 
manifold/ 
ventilator
… …
Anchor Tissue 2.) suture 3.) Silicone washer 5.) zip tie 4.) elastic bands
6.) 
drawstring
7.) 
socket
1.) 
Lunchbox 
Handle
Media Container
1.) one media 
chamber
2.) media reservoir & 
chamber
3.) Double media 
reservoir
… … … …
Emptying Media
2.) sloped 
bottom to 
collector
3.) plug 1.) valve 4.) vacuum ... … …
Gas exchange
2.) peroxide-
cured coil 
tubing
1.) filters 3.) oxygenator ... … … …
Means
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structure of the tube. The vertical flip method was one of our original ideas which involves attaching the 
tissue tube in a vertical manner in which flipping the media chamber up-side down would allow gravity to 
move the media through the lumen. As this method is similar to the rocking method, it would not be 
suitable for our project because it would cause turbulent flow. 
The intake manifold ventilator uses moving air to apply a pressure to the media which then 
propels the media through the tissue tube.  This method is very complex and involves many parts. 
4.1.2 Anchor Tissue 
The tissue sample has to be held in place while it is being fed.  Our group brainstormed different 
ways in which we could attach the sample to blunt-end syringes, needles, or tubes. Suturing is a common 
method used in the Rolle Lab when anchoring the tissue tube is necessary, such as during burst pressure 
testing.  Thus, suturing could also be used to anchor the sample onto the blunt-end syringes of our 
perfusion bioreactor.  The disadvantage to this would be that it is tedious and can potentially damage the 
tissue sample. 
Some alternatives to suturing include using small rubber washers, elastic bands, zip ties, or 
drawstrings.  The washers would be circular and flexible and could be placed over the ends of the tissue 
tube to anchor it to the ends of tubing or syringe needles. The elastic bands are very similar to the washer.  
They would be placed over the ends of the tissue tube to anchor it onto some other structure.  The 
potential disadvantage of using elastic bands is that they might break or damage the tissue. Zip ties would 
work like the sutures, but would simply be more user friendly.  However, it is uncertain how easy it 
would be to remove the zip tie once it is tied down, and it is likely that more tissue would be destroyed 
because zip ties are wider than sutures. 
The drawstring method was an original idea which consisted of a suture inside of a sleeve that 
could rest within the bioreactor even when it was not in use, unlike an ordinary non-reusable suture.  It 
would eliminate the initial looping of the suture, but would still require the step of tying, and due to the 
small scale of the components, the drawstring would be difficult to manufacture and use. The socket 
method involved two rings each with three flexible protrusions that would grip the tissue tube at either 
end.  However, due to the small size of the components the socket would be difficult to manufacture.  
Also, because the tissue tubes are so flimsy, it is likely that the tube would arch down in the center and 
slide off the sockets. 
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4.1.3 Media Container 
The perfusion bioreactor must hold a certain amount of media at any given time.  All of our 
designs require the tissue sample to be submerged in a container of media as well as receive media 
through the lumen.  We decided that there can be one media chamber, a media reservoir, or two media 
reservoirs. These are discussed below. 
The ―one media chamber‖ design does not incorporate a reservoir.  The media in the container 
would be pumped through a tube that can feed the lumen of the tissue.  From there the media would 
simply empty into the chamber to nourish the exterior of the tube and eventually be reintroduced to the 
flow loop through an outlet port.  One media chamber would make our device more portable because 
there would be fewer components.  Therefore, media may be used more efficiently because there would 
be no mixing of used media and fresh media.  Instead the media would be circulated until it is used up 
and then it could be swapped out with fresh media. 
 
Figure 8: The “one media chamber” design consists of a chamber that acts as the media reservoir as well as the area 
where the tissue sample is submerged.  The same media is circulated through the lumen as well as around the outside of 
the tissue tube, indicated by the single color of the media. 
 
The ―single media reservoir‖ design is a common feature among bioreactor designs.  There 
would still have to be a separate container of media that the sample is submerged in.  The advantages are 
that the media chamber could constantly be receiving fresh media.  The disadvantages to this method is 
that it will use more media than the ―one media chamber‖ design and there are more components so it is 
less portable, less durable, and more expensive. 
Chamber/Reservoir 
Tubing/Pump System 
Tissue Tube 
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Figure 9:The “single media reservoir” design consists of a media reservoir that contains the media that perfuses through 
the lumen (1, and yellow dotted line) and a second media reservoir where the tissue tube sample is submerged (2).  The 
two media reservoirs do not mix as indicated in the two separate colors. 
 
The double media reservoir consists of two separate but linked reservoirs.  The gas exchange 
takes place in the first reservoir, which then passes its media into a second reservoir.   
4.1.4 Emptying the Media 
Ideally, the media in our bioreactor will be changed every three days, if not longer.  The tissue 
tubes require about 6mL of media every four days and we anticipate that our design will incorporate more 
volume than 6mL. Thus, we expect that we can exceed our goal of changing media every 3 days. Our 
group brainstormed methods of emptying the media from the media container with this information in 
mind. 
A valve at the bottom of the media container could be opened to drain the media and closed to 
retain the media.  A plug would be very similar to the valve but might be more durable.  However, the 
plug must produce a leak-proof seal. If the bottom of the media container was sloped, the media could 
easily be drained through the valve or plug. 
In the lab there are aspirators that can remove excess liquid from tissue culture dishes.  
Aspirating media is an easy and efficient way to remove media when it is time to be replaced since it is 
readily available in the lab.  
4.1.5 Gas Exchange 
 The media must have gas exchange to provide the cells with oxygen while disposing of their 
excess carbon dioxide. Gas exchange is also needed for the CO2-mediated buffering of the culture 
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medium. A hole could be made in the media chamber or reservoir which allows air to come into contact 
with the media.  Also, a gap between components on the device could allow enough air flow between the 
inside and outside of the chamber without being too large to compromise the sterility of the environment.  
A filter could be used in order to prevent contamination if the gap or hole is large.   
Many bioreactors use a peroxide-cured coil of silicone tubing to produce gas exchange as it is air-
permeable.  However, this would add to the overall volume of media being used because media would be 
flowing through the tube at all times.  It is used in a coiled form to maximize the surface area for gas 
exchange while limiting the space it takes up. 
An oxygenator is a medical device used to carry out gas exchange in a patient who cannot use his 
or her lungs to do so.  This device is likely too large and expensive for our design. 
4.2 Design Alternatives 
 The following section describes the full designs that were considered for prototypes.  The 
designs incorporate features from the above sections to attempt to accomplish our objectives and operate 
within our constraints. 
4.2.1 Open Cartridge Design 
 The open cartridge design consisted of a subset of ideas which incorporated an inlet of a syringe 
needle coming from the wall and a stationary arm to hold the tissue tube in place. The name ―Open 
Cartridge‖ came from the idea that the end of the tissue tube is open to the chamber and not connected to 
a separate flow loop. The general idea behind this design is that the medium flows through the tissue tube 
and empties into the chamber.  Three different configurations were conceptualized. These include an arm 
with a syringe needle in the middle of the bottom face of the chamber (Figure 10), arms holding a syringe 
needle coming from the outlet face of the chamber (Figure 11), and a support arm with a circular trough 
for the end of the tissue in the middle of the bottom face of the chamber (Figure 12). The open cartridge 
designs are simple and would be easy to manufacture with readily available materials.  
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Figure 10: Open Cartridge Design 1 consists of a plastic arm (A) attached to the bottom face of the chamber. A syringe 
needle (B) is used to support the end of the tissue tube (C) while another syringe needle supports the other end at the inlet 
(D). 
 
Figure 11: Open Cartridge Design 2 consists of plastic supports connected to a syringe needle (A) to hold the end of the 
tissue tube (B) while a syringe needle on the inlet (C) holds the other end. 
 
Figure 12: Open Cartridge Design 3 consists of a plastic arm with a round support (A) underneath the tissue tube (B). 
The syringe needle at the inlet (C) holds the tissue open. 
 
A 
B C D 
A 
B 
C A B 
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 Additionally, there are limitations to the open cartridge designs. The supports are stationary so 
putting the tissue tube on the needles could be difficult. Also, design 3 does not provide enough support 
for the tissue tube and may cause it to collapse since there is nothing holding the lumen open.  
4.2.2 Lunchbox Design 
 Our first iteration of the lunchbox design, seen below in Figure 13, incorporated a tissue tube-
holding mechanism attached to the lid of the chamber. The lid had a handle on top for easy opening and 
transportation. This design is called the Lunchbox Design because of the original idea of having a handle 
on top. Posts with ring-shaped supports for the tissue tube extended down from the lid.  
 
Figure 13: Original Lunchbox Design with syringe needles embedded in the walls (A), a handle on the top of the lid (B), 
and ring-shaped posts to hold the tissue (C). 
  
This design would not have worked because the rings would not provide enough support for the 
tissue tube and would eventually collapse. Also, there was no way to move either of the arms to attach the 
tissue.  
A 
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Figure 14: Lunchbox Design with sliding Luer connection (A), sloped bottom for draining media (B), and sliding lid with 
long handle (C). 
 
 The next iteration included a sliding lid with a handle on the side, so that the top of the lid was 
flat as seen in C in Figure 14. By making the top flat, the user can flip it upright on the lab bench to 
prepare the sample. The lid slid into a ridge on the chamber to stay in place and to ensure a direct 
connection between the Luer connector and syringe needle at the inlet of the chamber. This design still 
incorporated two stationary arms but now included syringe needles to support the tissue tube. Luer 
connections between the inlet in the wall and the syringe needle in the arm created the flow loop after the 
lid was slid into place. The main idea behind this design was to allow the user to set up the tissue tube 
outside of the chamber and to easily attach the sample to the flow loop. The bottom of the chamber was 
sloped towards a plug for easy drainage.  
Unfortunately, this design was not practical. The stationary arms did not allow the tissue tube to 
be mounted easily. Also, the sloped bottom was not needed because media can be aspirated out, or the 
pump could be run in reverse. The long handle was also unnecessary because it made the chamber 
significantly larger. The chamber needed to be about twice as long as the span of the mounting arms to 
accommodate for the sliding motion. The arms needed to be submerged into the chamber before the lid 
was slid into its closed position. The sloped bottom and long handle would also require unnecessary 
machining.  
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4.2.2.1 Sliding Track Lunchbox Design 
 
Figure 15: The first iteration of the sliding track design. A sliding T-shaped arm (A) moved along tracks (B) in order to 
adjust the positioning of one of the syringe needles. 
 
 We altered the previous design to remove the side handle because it takes up space and increases 
the volume of the chamber significantly. As a result, this design has much smaller dimensions. The 
chamber has a height and width of 1.5‖ and a length of 3.75‖. The lid is 4‖ x 2‖. The main concern with 
all of the previous designs was movement of the arms for insertion of the tissue tube.  We designed a 
sliding track in order for the user to easily attach the tissue to each of the syringe needles.  This design 
was not used; however, because the arm was not easily secured in one place.  Originally it was thought 
that a pin-and-hole system (Figure 16) could be used on the moveable arm but this proved to be difficult 
to manufacture. Also, with a pin-and-hole system only exact fixation points could be chosen. Thus if the 
tissue varied slightly, the exact mounting position would not be attainable. 
 
Figure 16: Pin and hole track system that was considered for adjustability of the movable arm. 
A 
 A 
 B 
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4.2.3.2 Magnetic Track Lunchbox Design 
 
Figure 17: The magnetic track design includes a moveable arm with an embedded magnet (A). The lid had an embedded 
steel plate (B) with ridges along the side for guidance (C). 
 
 The idea of a magnetic track was considered as an alternative to the pin-and-hole system.  There 
were several distinct advantages of the magnetic track over the pin-and hole system.  First, this would 
eliminate the small parts required for the pin-and-hole system. Additionally, the lidconsists of a 
permanently attached magnetic surface and an arm with an attached magnet.  This would improve 
durability and lessen the amount of work required by the user.  Secondly, the pin-and-hole system only 
accomodates certain arm positions, while the magnetic track allows the user to customize the distance 
between the arms.  To provide stability and guidance for the moveable arm, ridges could be put on either 
side of the magnetic surface to hold the arm in place. This ensures that the syringe needles line up the 
same every time.  
 From our conceptual designs, we decided to move forward with the magnetic track design 
because it provided the user an easy way to manipulate the device for tissue tube attachment and 
adjustment. It is unique in that the tissue tube is hanging down and being submerged within the chamber. 
This design also incorporated the sliding lid mechanism which allows easy connection of the flow loop.  
 A 
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Chapter 5: Design Verification 
 This section describes the two prototypes and testing methods used to evaluate the designs. The 
results are also discussed. The protocols for all tests can be found in APPENDIX A: Testing Protocols. 
5.1 Magnetic Track Lunchbox Design Initial Prototype 
The first prototype was constructed out of Tupperware®, a magnet, wood, welded steel, 
aluminum, two 16 gauge syringe needles, two Luer connectors, 1/16‖ silicone tubing, and the peristaltic 
pump.  Images of this prototype can be seen in Figure 18.  The Tupperware® was used as a bioreactor 
chamber.   We cut two holes on either side of the Tupperware® and glued the two Luer connectors in 
place.  We constructed the lid out of wood and glued the 2‖ steel piece to it.  The steel was used as the 
magnetic track for the moveable arm.  Both arms were made out of aluminum and holes were drilled to 
accommodate the syringe needles.  The magnet was attached to the one arm by epoxy.  The inlet Luer 
connector in the Tupperware® connects to the Luer connector in the stationary arm of the lid to complete 
the flow loop.  This loop is completed by a sliding lock motion. Essentially, when the syringe tip is 
pushed against the male Luer connector, the friction between the two holds the lid tight to the chamber 
and establishes a flow loop.  We used Prince® Tubettini pasta to simulate the tissue tube.  
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Figure 18: The initial prototype consisted of a Tupperware® container (A) with outlet (B) and inlet (C) Luers, a wooden 
board (D) acting as the lid with a stationary aluminum arm (E) and steel track (hidden by the paper labeled by F), and a 
magnetic aluminum movable arm (G). Both arms have aligned syringe needles (H). The paper was used to even out the 
height of the movable arm. 
 
Once the prototype was built we could start the proof of concept testing.  We tested the 
prototype’s ability to create a full flow loop, the pump’s flow rate, and the ease of anchoring the Tubettini 
to the device. Before any of these tests could be performed, we had to make sure that our prototype did 
not leak.  We filled the Tupperware® container with water and did not observe any leakage around the 
glued Luer connectors.   
Next, we attached the Tubettini pasta onto the syringe needles.  We tried to suture the Tubettini 
to the syringe needles but the pasta started to rip.  We removed the ripped pasta and attached another 
piece without anchoring it to the syringe needles in order to proceed with testing.   
We placed the lid onto the Tupperware® and proceeded to pump the water through the pump and 
through the pasta.  At first, we did not observe any flow going through the pasta so we removed the lid 
and examined the syringe needles.  The syringe needles were clogged with pasta residue that collected 
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inside the needles while the pasta was being attached.  We moved the piece of pasta to one needle and 
unclogged the syringe needles. 
To ensure that it was unclogged, we pipetted water through each syringe needle.  The water 
flowed effortlessly through the syringe needles.  Then we positioned the pasta back in place over both 
syringe needles and proceeded to pipette water through.  The water flowed through the syringe needle 
and the pasta and out the other syringe needle.  There was no leakage where the syringe needle attaches 
to the pasta. 
 The next test performed was measuring the flow rate of water through the prototype in order to 
determine what setting of the pump we needed to use. The pump we used to test the flow rate was the 
Fisher Scientific Variable-Speed Pump Low Flow (model number 13-876-1) that ranged from 0.003-
8.20mL/min and can be seen in Figure 19.  The dials on the pump do not specify the flow rate so they 
needed to be calculated.  In order to calculate the flow rate, we filled the silicone tubing and chamber 
with water and ran the pump on the different speed settings.  The water emptied into a graduated 
cylinder.  We measured how much water was in the graduated cylinder after three minutes. 
 
Figure 19: Fisher Scientific Variable-Speed Pump Low Flow was used to pump fluid through the bioreactor. Flow rates 
ranged from 0.003-8.20mL/min. 
 
The pump settings were recorded and the total volume was divided by three minutes in order to 
obtain units of milliliters per minute. We chose to set the speed to ―Fast‖ and the dial setting to 7 and 10.  
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The fastest setting was dial 10, at 6.3mL/min.  At seven, the flow rate was 4mL/min. We chose to use the 
pump at 6.3mL/min because this rate fell within the acceptable wall shear stress range of 4.4-8.8mL/min, 
which is different than the necessary 7.16-14.3mL/min because we had made errors in our calculations at 
the time of this experiment. The results of this test can be found in Table 4. 
 
Table 4: Results of the Low Flow pump flow rate test. 
Test Setting Volume (mL) after 3 min Flow Rate (mL/min) 
1 10 Fast 19 6.3 
2 7 Fast 12 4 
5.2 Magnetic Track Lunchbox Design Acrylic Prototype 
 
Figure 20: The components of the acrylic prototype chamber consist of a cut out for the placement of the lid (A), inlet 
female Luer connector (B), outlet male Luer connector (C), and two rectangular gaps for the track ridges to slide on (D). 
The components of the acrylic prototype lid consist of ridges for guidance of the moveable arm (E), an embedded steel 
track (F), a moveable arm (G), a stationary arm (H), and a male Luer connector for the wall connection (I). 
 
The acrylic prototype optimizes size while taking advantage of quality materials and precision 
machining. The acrylic design is comprised of three separate but connectable parts, all made out of acrylic 
with a few smaller stock parts required for functionality. The three main components are the chamber, the 
lid, and the movable arm. All of the components described in this section can be seen in Figure 20.  
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The chamber was designed to have an open top, a threaded hole in the front wall, and a threaded 
hole on one of the sidewalls. The chamber was milled down to the correct conformation using a milling 
machine. The chamber is 3.5 inches long, 1.0 inch tall, and 1.65 inches wide.  The wall thickness of the 
chamber is 0.25 inches, and thus its depth is 0.75 inches. The back wall’s height is 0.88 inches, and the 
three other walls are 1 inch tall, resulting from an indent that goes .12 inches into each wall.  Two 
standard ¼-28 ANSI Inch threaded holes were drilled into two of the chamber walls. Both holes are 
threaded with ¼-28Ansi Inch screw threading.  The front hole has a diameter of .21 inches and the side 
hole has a diameter of .16 inches. 
A female threaded barbed Luer connector was used for the inlet, labeled B in Figure 20, with the 
female Luer connection facing into the chamber and the barb on the outside. The outlet, labeled C in 
Figure 20, was moved from the side to the front wall because the Luer extends into the chamber and 
would cause the chamber to be longer than necessary. The top edge of the chamber had three sides carved 
out to create an edge that the lid could slide into that can be labeled A in Figure 20 and highlighted in 
yellow in Figure 21. Slots were etched into the top of the rear edge of the chamber. These slots, labeled D 
in Figure 20 and labeled with arrows in Figure 21, were created so that the ridges on the lid would not 
collide with the rear wall when the lid is sliding on or off. 
 
Figure 21: Acrylic prototype chamber with edges for lid (highlighted in yellow) and slots for ridges on lid (labeled with 
arrows). 
 
The second major component is the lid, which features a stationary arm for mounting as well as a 
track for a moveable arm to slide across. The stationary arm can be seen in C of Figure 22.  The lid is 
3.375 inches long in order to fit over the indent of the front chamber wall as well as the surface of the 
back wall.  It is 1.40 inches wide and .25 inches thick.  This stationary arm’s frontal face is positioned 
.38 inches from the frontal face of the lid and it is also .38 inches long.  Its width is .5 inches. The 
inlet 
outlet 
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stationary arm was fitted with a ¼-28 ANSI Inch threaded hole so that a threaded male Luer could be 
screwed into place.  The male Luer connector was positioned to connect with the female Luer of the 
chamber.  A .05 inch diameter unthreaded hole was drilled through the rest of the arm. An 18-gauge 
needle was tapped into this hole until about a half inch of needle was exposed.   
The lid was also milled to have two 1.1 inch ridges protruding out of the bottom of the lid.  
These ridges seen in A of Figure 22, which are each .2 inches thick and .1 inches tall, have their back 
ends positioned .93 inches from the back edge of the lid and are spaced apart .75 inches. These ridges fit 
into the slots of the chamber when the lid is sliding on. The lid was also milled with a rectangular 
depression on the exterior so that a steel bar could be pressed in.  This depression measures 2.0 inches in 
length, .75 inches in width, and .19 inches in depth. A piece of steel was cut so that it could fit into the 
hole. The fit was sufficient that no adhesive was needed to keep the steel in place. The steel serves as the 
magnetic track and is separated from the cartridge by the remaining layer of acrylic. 
 
Figure 22: Acrylic prototype lid consisting of ridges (A) for the moveable arm (B) and a stationary arm (C). Arrows 
indicate the dimensions of the depression for the steel piece. 
 
The movable arm, seen in B of Figure 22, was created using a small acrylic block, an 18-gauge 
needle and a neodymium magnet.  The acrylic block was milled to be .375 inches long, .75 inches wide, 
and .50 inches in height. A hole .05 inches in diameter was drilled through the movable arm to match the 
hole previously created in the stationary arm.  The 18-gauge needle was lined with superglue and placed 
inside of the movable arm so that a similar amount of needle was exposed. When lined up with the needle 
of the stationary arm, a tissue tube can be sutured and stabilized. The movable arm was also created with 
a circular cutout in the base in order for it to house a disk-shaped neodymium magnet.  The magnet is .5 
inches in diameter and .13 inches thick, so the hole was made to accommodate that size. Epoxy was used 
to attach the magnet to the movable arm.  The attraction between the magnet of the movable arm and the 
steel embedded in the lid provides enough force for the movable arm to adhere to the lid. 
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 The first test performed on the acrylic prototype was to measure the volume the bioreactor could 
hold.  This was done by filling the chamber with water, adding the lid, and removing any excess. The 
water had to be raised above the syringe tips because the tissue tube would have to be completely 
submerged in media when the device was in use. Next, the water was poured into a graduated cylinder for 
measuring.  This simple test was repeated two times and we determined the average volume of the 
bioreactor to be 25mL.  
 Our second test involved calculating and comparing various flow rates of the pump. The pump 
used was Fisher Scientific Variable-Speed Pump -Medium Flow (part number 13-876-2) that has flow 
rates of 0.4mL/min-85mL/min pump, shown in Figure 23.  This pump was used instead of the previously 
mentioned Low Flow pump because the Low Flow pump’s maximum flow rate was only 8.2mL/min. 
According to our calculations, we needed a flow between 7.16 and 14.3 mL/min. We used one of the 
pieces of tubing that came with the Fisher Scientific pump (3/16‖) inside the rotating mechanism of the 
peristaltic pump.  We tested the flow rates by attaching the inlet of the pump to tubing in a beaker of 
water and the outlet to an empty graduated cylinder.  The pump was run at various settings for 3 minutes.  
At the end of three minutes the total volume was divided by three in order to obtain a flow rate value in 
mL/minute.  The results of this test can be seen below in Table5.  
Table5: Flow rates of 0.4-85 mL/min peristaltic pump. 
Pump 
Setting 
Flow Rate 
(mL/min) 
Velocity 
(cm/sec) 
Wall Shear Stress 
(dynes/cm
2
) 
Reynolds 
Number 
2 (slow) 5.33 7.99 3.62 119 
1 (fast) 8.00 12.0 5.43 178 
1 (fast) 8.33 12.5 5.65 185 
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Figure 23: Fisher Scientific peristaltic pump with flow rates ranging between 0.4-85.0mL/min. 
 
 We then checked for leaking through the arms of the lid since having no leakage is one of our 
constraints.  This was done by pipetting colored water through the Luer connector on the stationary arm 
while the lid was laid flat on the bench top.  Water moved all the way through the syringe needle.  
Unfortunately, we saw some leaking from the threading of the Luer connector on the stationary arm. An 
image of the leak can be seen circled below in Figure 24. There was no leaking on the opposite side of the 
stationary arm where the syringe needle was tapped in.  
Setting Dial 
3/16‖ tube 
1/16‖ tube 
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Figure 24: Leak around threading of the stationary arm (circle). No leaking was observed at the stationary arm-syringe 
needle interface (arrow). 
 
 The whole flow loop was tested for leaking by suturing a 1.47mm inner diameter clear silicone 
tube resembling the tissue tube onto the syringe needles.  Since our prototype chamber is not translucent, 
we did this test with the lid alone on the bench top.  A female Luer was attached to the male Luer of the 
stationary arm. The 1/16‖ tubing was attached from this female Luer to the pump. The pump inlet tubing 
was set in a beaker filled with water. The pump was turned on in order to release any air bubbles. No 
leaking was observed from either syringe needle, or from the sutured tubing.  All the water successfully 
emptied through the end of the other syringe needle. The leak-free sutured tube is shown below in Figure 
25.  As mentioned before, there was leaking at the threading of the Luer connector in the stationary arm. 
The leaking was fixed by applying Teflon tape to the threading of the Luer connector. 
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Figure 25: No leaking was observed around sutured tubing. In this image the sutures (A) and the silicone tubing (B) are 
shown. The inlet (D) and outlet (C) are also visible. 
  
 Finally, the bioreactor was tested to see if flow was laminar through the region where the tissue 
tube would be attached. As mentioned in the previous paragraph, 1.47mm inner diameter clear silicone 
tubing was sutured on the ends of the syringe needles to simulate the tissue tube while providing a 
transparent material. Next, a beaker was filled with water and green sugar particles. Using the peristaltic 
pump, this solution was flowed through the clear silicone tube. The motion of the particles was recorded 
using a camcorder and later reviewed for analysis. The full protocol can be found in Appendix A. There 
appeared to be turbulent flow based on the movement of the particles. Some particles seemed to move 
straight across the tube while others swirled and flowed in circles. However, it was later realized that the 
particles were not of uniform size and could be affecting the flow. This test was deemed inconclusive. 
Figure 26 shows the different sized particles flowing through the silicone tube.  
 
Figure 26: Silicone tubing (ID 1.47mm) was sutured to the syringe needles (A). Both large (B) and small (C) particles are 
seen flowing through the tubing. 
A A 
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After testing, we found that this prototype meets some of our design objectives. Attaching and 
suturing silicone tubes to the device were simple processes due to the mobility of one of the arms.  The 
attraction of the magnet on the movable arm to the steel created enough force to hold the silicone tube 
without shifting.  This force was well balanced and the movable arm easily slid along the track. The 
movable arm was also easily removed when slid to the end of the steel track. Without hindering the 
functionality of the chambers, we significantly downsized the dimensions to reduce the amount of media.   
Another positive feature of the design is that the Luer connectors are all replaceable since no permanent 
bonds were used to attach them to their respective locations.  
 Despite the general improvements made to this prototype over the previous prototype, several 
flaws were still noted. When the lid is slid over the chamber to make the Luer wall connection, the device 
is sealed. However, sometimes this connection is made too tight and needs to be forcefully removed. The 
motion of forcefully opening the lid may inadvertently cause the movable arm to collide with the wall of 
the chamber.  The collision would be detrimental to any tissue tube mounted, as the movable arm’s 
position is affected when it hits the chamber wall. 
 Another flaw in the acrylic design is that the two 18-gauge needles, which secure the tissue tube, 
do not line up perfectly. Since the placement of the holes for the needles were precisely measured (to the 
thousandth of an inch), we speculate that the reason for the misalignment is because the layer of epoxy 
used to attach the magnet to the movable arm was not accounted for. 
 The slots built into the side of the design were deemed to allow too much contact with the outside 
environment. Large gaps in the exterior of the device can compromise the sterility of the design. 
 Testing the perfusion capabilities of the acrylic prototype enabled us to find a leak where the male 
Luer connector meets the stationary arm. The flaw could potentially be attributed to imperfections of the 
threading. The acrylic may also be cracked at some point, since the 18-gauge needle was tapped into the 
hole drilled through it.  
 In conclusion, our acrylic prototype showed that our design concept was feasible. By testing the 
acrylic prototype we were able to identify the flaws of the design. Creating a final prototype allowed us to 
improve upon this concept. We decided to take this design to the next step and create it out of a material 
able to undergo autoclaving in order to be able to test with biological samples.   
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Chapter 6: Final Design and Verification 
The following chapter describes the components and features of the final design of the device.  
Manufacturing of the device, including parts used, measurements, and the procedure for making device is 
also included in the chapter. Testing of the device and the corresponding results are also in this chapter. 
6.1 Verification 
 Several changes had to be made from our acrylic prototype to produce a suitable perfusion 
bioreactor.  First, the material had to be changed.  Acrylic melts in autoclaves, so we needed to find a 
material that could resist the temperature and pressure of an autoclave.  Polycarbonate was suggested to 
us for use by our consultants Neil Whitehouse and Michael Fagan.  We purchased polycarbonate to 
create our final device after careful research and consideration of its properties. 
 Next, we had to alter the lid design so that it was better suited for aseptic techniques.  Referring 
to Table 1, our Pairwise Comparison Chart Results, it is evident that the most important objective to be 
met was ―ease of sterilization.‖  Sterility was also a constraint.  The acrylic prototype’s lid slid into the 
chamber and was held in place by thin walls.  Our clients wanted a lid design which would hang over the 
edges of the chamber rather than fitting within it.  The idea was based on the properties of a Petri dish; 
the overhanging lid would provide additional protection from contamination on the surfaces of the 
chamber while still promoting gas exchange and featuring the easy-to-use sliding mechanism.  In 
addition to the new lid design, the chamber would have slots cut out for the ridges of the lid to fit in.  We 
realized that the acrylic prototype’s slots had too much clearance; there was open space even when the lid 
was connected. This increased the likelihood of contamination.  The final step was to cover over the 
magnet and piece of steel with some form of polymer to prevent rusting in or around the chamber.  Rust 
could cause the media inside the chamber to become cytotoxic. 
 A few matters of efficiency and poor planning had to be addressed during the manufacturing 
process.  The moveable arm was made smaller as there was excessive material used in the acrylic 
moveable arm.  Due to the shape of a drilling tool used to drill a hole in the stationary arm, a region had 
to be bored out of the lid in front of the stationary arm.  This hollowed out area, shown in Figure 28 (A), 
was embraced as a new means of gas exchange. 
 Based on these changes, the device would now meet the criteria for our sterilization constraints 
and objectives.  Laminar flow was tested multiple times and ultimately our conclusion was that the tests 
indicated little to no turbulence.  Polycarbonate is highly durable, and although the device was not tested 
under stresses to see if cracking or bending occurred, we can say from handling the device that it does not 
seem to be at all fragile.  In general, the device was fairly easy to make.  As with any new device, there 
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were some mistakes made during the initial manufacturing process.  Our suggestions for avoiding these 
mistakes are outlined in the Future Recommendations section.  Our device is quite easy to use; the only 
part of using it which should offer any trouble is mounting the tissue tubes.  However, considering the 
method of tube mounting we employ (suturing) is consistent with current practice in the Rolle Lab, and is 
being used to perform burst pressure testing.  Other than the mounting process, our device only requires a 
bare minimum of upper body strength to attach and detach the lid.  Because of its size, the bioreactor is 
quite portable, and we met our ―adjustable‖ objective by engineering a lid with arms that could be 
adjusted for holding variable length tissue tubes.  Our device was fairly inexpensive, as we were able to 
stay within our budget while making two prototypes and the final device. 
6.2 Final Design 
The final design uses aspects of the acrylic prototype, but with some major changes to improve 
functionality.  The main components of the final design were made with polycarbonate instead of acrylic.  
All of the dimensions of the final design can be found in APPENDIX B: Final Design CAD Drawings.  
The chamber of the device is represented by Figure 27.  The chamber has suitable space to hold 
media, as well as two threaded holes for the inlet and outlet Luer connectors.  The inlet Luer connector is 
Part No. PBR-007 and is represented by A of Figure 27.  This part consists of a barb, followed by a 
threaded segment, and finally a female Luer component.  The female Luer component protrudes from the 
inner wall of the chamber.  The outlet Luer connector is Part No. PBR-006 and is represented by B of 
Figure 27.  The outlet Luer consists of a threaded segment and a male Luer connection segment. The 
male connection can connect to any standard female Luer with a barbed end, such as Part No. PBR-007.  
The chamber also has two slots that accommodate for the ridges of the magnetic track and allow the lid to 
slide.  These slots are located at the top of the side opposite the inlet Luer, and are represented by C in 
Figure 27. 
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Figure 27: Final design chamber showing female inlet Luer (A), male outlet Luer (B), and slots for ridges on lid (C). 
 
Modifications were made to the lid to help prevent contamination.  The lid of the final design is 
represented by Figure 28. The length and width of the lid was extended so that the lid could fully cover 
the cartridge.  As seen in Figure 29, the lid overhangs the cartridge to protect the chamber’s surfaces 
from potential contamination.  A small steel plate is embedded within a depression located on the top of 
the lid. Silastic® Medical Adhesive, a silicone sealant, was used to cover over the steel. Another feature 
of the final design lid is the arc cutout located above the inlet Luer. This opening allows gas exchange 
between the chamber and the incubator. The arc cutout can be seen in Figure 29. 
The movable arm, represented by B of Figure 28, was modified from that of the acrylic design so 
that the neodymium magnet could be embedded deeper into it.  The movable arm of the final design is 
also wider than that of the acrylic design so that it can hold the entire magnet within it.  Silastic® 
Medical Adhesive was used to seal the neodymium magnet in the movable arm. An 18-gauge syringe 
needle, Part No. PBR-005, goes through most of the movable arm.  The male Luer connector, Part No. 
PBR-006 and represented by C of Figure 28, allows media to be perfused through the stationary arm. 
Another 18-gauge syringe needle goes through the stationary arm. As seen in Figure 30, a tube can be 
mounted on the 18-gauge syringe needles.  
 A 
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Figure 28: Lid of the final design, which includes the stationary arm (A), the movable arm (B), male Luer connector (C), 
the ridges for the magnetic track (D), and 18-gauge syringe tips (E). The movable arm’s movement is illustrated by the 
yellow arrow.  
 
 
Figure 29: Arc cutout of the lid that enables gas exchange (A). The overhang of the lid can also be clearly seen here (B). 
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Figure 30: Silicone tube mounted onto the syringe tips using medical sutures (arrows). 
6.3 Manufacturing of the Final Design 
The chamber of the final design, as seen in Figure 27, was created by first milling an opening into 
a polycarbonate brick.  A HAAS Toolroom Mill, model T-1, was used for all milling done to the 
chamber. The chamber was milled to be 3.5‖ long, 1.0‖ tall, and 1.65‖ wide.  The opening was milled so 
that the thickness of the walls of the chamber on all sides is .25‖. Two slots were milled at the top of one 
of the 1.75‖ edges to accommodate for the ridges of the magnetic track on the lid.  They are each 0.2‖ 
wide and 0.1‖ deep.  These slots are labeled as C in Figure 27. 
After the milling, two threaded holes with measurements of ¼-28 ANSI Inch were drilled into the 
device. This was so that inlet and outlet Luers could be inserted. The hole for the inlet Luer, located at A 
of Figure 27, was drilled on the 1.0‖ by 1.75‖ face, 0.32‖ below the top of the cartridge. The female inlet 
Luer, Part No. PBR-007, was inserted so that the barb was on the outside of the chamber.  The hole for 
the outlet Luer, located at B of Figure 27, was drilled on the 3.5‖ by 1.0‖ face, at the bottom of the 
chamber. The outlet Luer, Part No. PBR-006, was inserted with the male Luer facing away from the 
chamber. The threading of both Luers was lined with Teflon tape to prevent leaking. Refer to the 
Appendix B: Final Design CAD Drawings for the CAD representation of the chamber.  
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The first step in manufacturing the lid of the final design was using the HAAS Toolroom Mill on 
another polycarbonate brick.  The lid was milled to be 5.0‖ long, 2.15‖ wide, and .50‖ tall. A rectangular 
depression 1.50‖ long, .75‖ wide, and .22‖ deep was milled into the top of the lid. The mill also created 
the block for the stationary arm, represented by B of Figure 28. The last feature created by the mill was 
the ridges used to guide the movable arm on the magnetic track. Each ridge measures 2.5‖ in length, .20‖ 
in width, and .1‖ in height.  The ridges are labeled as D of Figure 28.   
The next step in manufacturing the device was to ensure that the lid and chamber fit together 
properly. The edges of the cartridge needed to be curved so that it could fit with the lid, since the mill cuts 
rounded edges. The edges were curved by using wet sand paper while rotating the device. The mill also 
left residue and uneven surfaces on the polycarbonate lid, and the slots for the magnetic track on the 
chamber were not cut through all of the way.  A scalpel, sanding paper, various files, and a sanding belt 
were used to polish the surfaces and remove the excess polycarbonate.  The sanding belt used was 
Hammond of Kalamazoo’s Model PD-10. 
Once the lid and the cartridge were sanded down, a piece of steel was cut for the magnetic track.  
The steel was cut using the blade saw on DoAll’s Model No. DBW-12B Butt Welder. The steel was 
inserted into the depression in the lid and was sealed in with epoxy. After the steel was placed into the lid, 
the movable arm needed to be made.  A small piece of polycarbonate was cut and milled using DoAll’s 
Model No. GPM 2CCV. The resulting brick measured .75‖ in width, .75‖ in length, and .52‖ in height. 
Refer to the APPENDIX B: Final Design CAD Drawings for the CAD representation of the movable arm 
block.  A hole was milled out of the brick so that the neodymium magnet can be embedded.  Epoxy was 
used to embed the neodymium magnet.  Acquired from K&J Magnetics, the magnet itself is an N-52 
grade neodymium disk magnet measuring .5‖ in diameter and .125‖ in height. This hole measured .519‖ 
in diameter and .12‖ in depth.  
Model No. GPM 2CCV was also used to drill a hole through the brick. This hole was made so 
that the 18-gauge blunt needle could fit into the movable arm. The device as a whole needed two 18-
gauge needles. These needles were obtained by cutting the needle portion off of blunt end syringe tips. 
The lengths of the resulting 18-gauge needles varied slightly, but were always less than 1.0‖.  The first 
18-gauge needle was fitted into the movable arm. A small amount of super glue was used to secure the 
needle inside of the hole. At this point manufacturing of the movable arm was complete, but the epoxy 
needed to be left to dry.  The complete movable arm is represented by B of Figure 28. 
The next step in manufacturing device was to drill the ¼-28ANSI Inch threaded hole into the 
stationary arm.  A .05‖ hole for fitting the 18-gauge needle into the stationary arm was also necessary.  
The DoAll Model No. GPM 2CCV machine was used for both tasks.  However, the portion of the lid 
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above the inlet Luer was preventing the drill from accessing the stationary arm. An arc shape was cut out 
of the lid so that the drill could reach the arm.  Figure 29portrays the arc cutout. The hole for the 18-
gauge needle was created by drilling through the bottom of the ¼-28 ANSI Inch hole and out the other 
side of the stationary arm.  To complete the stationary arm, the second 18-gauge needle was lined with 
superglue and inserted into the .05‖ hole.  The male Luer connector, Part No. PBR-006, was lined with 
Teflon tape and threaded into the ¼-28 ANSI hole.  The complete stationary arm is represented by A of 
Figure 28. 
At this point the final design was fully constructed.  However, after testing the device, it became 
clear that a few modifications needed to be made.  The female inlet Luer did not line up with the male 
Luer connector of the stationary arm.  The top of the chamber was sanded down until the two lined up 
and a connection could readily be made. The two 18-gauge needles were not level with each other.  To 
fix this, the bottom of the movable arm was sanded down until the two were level.  Also, the epoxy did 
not retain its shape when autoclaved.  The magnet in the movable arm and the steel piece in the crevice 
of the lid were removed so that they could be sealed in with another substance. Silastic® Medical 
Adhesive was chosen to replace the epoxy.  After these modifications were made, the manufacturing of 
the device was complete. A CAD representation of the exploded view of the device in its entirety can be 
found in APPENDIX B: Final Design CAD Drawings. 
6.4 Final Design Testing 
In order to determine if the changes we made to our design fixed the previous problems with our 
prototypes and met the objectives of our project, we conducted a series of tests. The protocols for the 
testing of the final design can be found in APPENDIX A: Testing Protocols. 
6.4.1 Laminar Flow Testing 
Laminar flow was tested in three different ways with our final design. All three tests used food 
coloring as dye. The first laminar flow test involved flowing clear water through 1.47mm inner diameter 
silicone tubing sutured onto the syringe needles and then introducing colored water. This was performed 
with the lid upright on the workbench and was recorded with a camcorder for further analysis. The flow 
loop was primed with clear water, the pump was stopped, and food coloring was injected via pipette into 
the end of the 1/16‖ pump tubing. Once the food coloring was in the system, the pump was turned back 
on and the dye flowed through the sutured tubing. 
 The next laminar flow test involved injecting food coloring into the 1.47mm inner diameter 
silicone tubing as the clear water ran through the system. First, blue food coloring was put into a syringe 
B C 
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and a 30-gauge needle was attached. Then, with the lid on the tabletop, the flow loop was primed with 
clear water. Once the sutured tubing was full of water and free of any bubbles, the needle was used to 
pierce the tubing and food coloring was injected into the stream of flowing water. This was recorded with 
a camcorder for later analysis.  
 The third and final laminar flow test was performed by injecting the food coloring upstream from 
the bioreactor. The bioreactor, pump, tubing, and needle with food coloring were set up as previously 
described in laminar flow test 2. The flow loop was primed with water. The 30-gauge needle was used to 
inject food coloring into 1/16‖ silicone tubing that connected from the pump outlet to the lid inlet just 
before the inlet Luer. As with the previous tests, the camcorder was used to record and analyze the data.  
6.4.2 Sterility Assessment 
  Before the bioreactor can house living tissue, we must ensure that it is a sterile environment.  
We performed three sterility assessments.  First we autoclaved the bioreactor and tubing for fifteen 
minutes.  We then proceeded to open the autoclave bags in the sterile hood and set everything up inside 
the hood.  The bottle of media was wiped down with 70%ethanol and placed in the hood.  Next we 
connected the tubing to the inlet and outlet Luer connectors in the chamber and pipetted 26mL of DMEM 
media into the chamber.  Then the lid was carefully placed on the chamber and locked in place.  Lastly, 
we carried the bioreactor to the incubator.  The bioreactor was placed in the incubator for 48 hours. The 
media was poured into a cell culture flask and observed under the microscope for potential contamination.  
We used Trypan Blue to stain the media to easily identify any microorganisms or particulates. 
 The second sterility assessment we ran followed the same autoclave procedure, except that we 
also autoclaved sutures and 1/16‖ silicone tubing.  We opened everything in the sterile hood and wiped 
the pump, a beaker, a plastic tray, and the bottle of DMEM media with 70% ethanol.  This time we 
placed the chamber into a plastic tray for easier transportation and to collect any potential spills.  This 
setup can be seen in Figure 31.  Next we ran the pump with a beaker full of media as a source and the 
bioreactor chamber as a destination to prime the tubing and fill the chamber.  Once the tubing and 
chamber were filled with media we sutured a 1.47mm inner diameter silicone tube with a length of 1cm 
onto the syringe tips.  The lid was carefully placed on the chamber and locked in place.  The water pan 
in the incubator was filled about halfway with distilled water then the bioreactor and pump were placed in 
the incubator for 48 hours as seen in Figure 32.  We checked to make sure everything was still running at 
the 24 hour mark.  The media was poured into a cell culture flask and observed under the microscope for 
potential contamination. 
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Figure 31: (A) Beaker containing media, (B) bioreactor chamber in plastic tray, and (C) pump being set up under a sterile 
fume hood. 
 
 
Figure 32:(A) Pump and (B) bioreactor set up in the incubator. 
 
 The last sterility assessment we conducted followed the same autoclave procedure as the second 
test.  We opened everything in the sterile hood.  This time we added 3mL of fetal bovine serum to the 
27mL of media in order to create a 10% FBS media solution. Because our tissue tube samples were not 
ready we wanted to test a living sample, rather than the silicone tubing.   Rat carotid artieries were 
obtained from the Physiology and Engineering Lab and IACUC-approved procedures were followed 
when sacrificing the animals. Rat carotid arteries were chosen because they are similar in size and 
fragility to the tissue tubes.  We attempted to mount the rat carotid arteries on the syringe needles but 
were unable to do so due to the lumens of the arteries being too large to fit snuggly on the syringe 
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needles.  We resorted to using the 1cm long piece of 1.47mm inner diameter silicone tube.  We wiped 
the tube and the syringe tips with 70%ethanol before suturing it to the syringe tips. After filling the tubing 
and chamber with the media solution, the lid and chamber were connected. We placed the pump and the 
plastic tray with the bioreactor in the incubator for 24 hours.  We checked to make sure everything was 
still running at the 24 hour mark.  Then the media was poured into a cell culture flask and observed under 
the microscope for potential contamination. 
6.4.3 Leakage Tests 
 We performed two leakage tests.  The first leakage test was to ensure that there was no leaking 
around any of the Luer connectors.  We filled the chamber with water and observed.  The second 
leakage test we performed was to ensure that there was no leaking at the tissue-syringe interface as seen 
in Figure 25.  This test was conducted without the chamber because the walls of the chamber make it 
difficult to observe leaking.  We attached a female Luer connector to the stationary arm Luer connector. 
We then connected the pump with the inlet Luer connector using 1/16‖ tubing.  Next we sutured a 1cm 
piece of 1.47mm inner diameter silicone tube to the syringe tips in order to simulate the tissue tube.  This 
setup can be seen in Figure 33. 
 
Figure 33: Female Luer connector (A) attached to the stationary arm (B) to complete flow loop when lid is being tested. 
 
6.4.4 Volume Test 
 In order to measure how much media the bioreactor would hold, we filled the chamber with 
water.  The objective was to hold enough media for three days.  We filled the chamber with water so 
A B 
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that it was above the inlet Luer connector but not spilling out the back ridge slots.  Then we locked the 
lid in place and observed if any water spilled out of the slots. 
6.4.4 Histological Analysis 
Once our bioreactor passed the sterility tests, we were ready to test real tissue tubes in our bioreactor.  
First, we autoclaved the bioreactor, tubing, and sutures.  We opened everything in the sterile hood and 
wiped the pump, a beaker, a plastic tray, the centrifuge tube of fetal bovine serum, and the bottle of 
DMEM media down with 70% ethanol.  Two batches of cell media were made. Each batch consisted of 
10mL fetal bovine serum, 50mL of DMEM, and 500µL of Pen-Strep.   
The tissue tube samples used had been grown in static culture for 19 days. Along with Zoe 
Reidinger, we attempted to mount multiple tubes to the bioreactor but they either ripped or had 
deformities. Our third attempt of mounting a tissue tube onto the syringe needles was successful, 
however.    To attach the tissue to the bioreactor, the tissue was slid off of the silicone mandrel onto the 
syringe needle of the movable arm. Then, the needles of the movable arm and stationary arm were aligned 
and the tissue tube was partially slid onto the stationary arm needle. The movable arm was adjusted so 
that the tissue tube was suspended between both syringe needles. Once the tissue is in place, it is sutured 
onto the syringe needles. Finally, the chamber is filled and the tubing is primed with media by running the 
pump. This procedure is depicted in Figure 34, below.  
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Figure 34: 1&2) Tissue tube is slid off of the silicone mandrel and onto the syringe needle of the movable arm. 3) Syringe 
needles of both arms are aligned and the tissue tube is moved between both. 4&5) Movable arm is moved back so that the 
tissue is suspended between both arms and the ends are sutured onto the syringe needles. 6) The pump outlet is connected 
to the chamber inlet. 7) The chamber is filled with media by running the pump to move media from beaker. 8) Inlet of 
pump is attached to the outlet of the chamber and the lid is connected. 9) Pump and bioreactor are placed in the 
incubator for 3 days. All of these steps were performed with the help of Zoe Reidinger. 
In order to assure that no leaking was present at the tissue-syringe interface and the Luer-tubing 
interface, we connected barbed female Luer to the male Luer in the stationary arm and flowed media 
through to check for leaks as seen in Figure 35. Then we locked the lid onto the chamber.  We added 
distilled water into the tray in the incubator before placing the pump and bioreactor in the incubator.  We 
ran the system for three days checking once every twenty-four hours.  Then we removed the bioreactor 
and the pump at the three-day mark.   
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Figure 35: Media flows all the way through the tissue tube and comes out the end of the movable arm (A). No leaking is 
observed at the tissue-syringe interface or the Luer-tubing interface (B). Media flows from a beaker through the tubing 
and into the arms of the lid, priming the tubes in the process (C). 
 We preserved one 19-day-old tissue tube by treating it with 10% neutral-buffered formalin (NBF) 
for 45 minutes.  This sample was stored using 70% ethanol.  This tissue tube served as the starting point 
for the tubes grown in the bioreactor and static culture.  We cultured three tissue tubes statically (on the 
silicone mandrels) for the same amount of time as the dynamic bioreactor culturing. At the 24 and 48 
hour marks, the tissue tubes in static culture were fed with 6mL of the media described earlier and after 
72 hours, the tissues were harvested along with the bioreactor tissue tube. Histological analysis was 
performed by Zoe Reidinger, which included preserving the tissues in the same manner as the 19-day 
tissue tube, then embedding the samples in paraffin, slicing the samples, mounting them onto microscope 
slides, and staining with H&E, Hoechst stain, and smooth muscle alpha actin stain. 
 All samples were preserved with 10% neutral-buffered formalin and stored in 70% ethanol, just 
like the nineteen-day old tissue tube.  Samples were removed from the ethanol and run through a series 
of chemicals which replaced the water in the samples with wax. The preserved tissue tubes were 
embedded in paraffin and cut transversely into 5 µm sections and mounted on microscope slides.  Some 
of the slices from each sample were stained with H&E so that the cell morphology and nuclei could be 
viewed under a microscope.  
The preserved samples were viewed under a Leica microscope. Three tissue tube samples were 
viewed: the tissue tube incubated in the bioreactor, one of the 22-day statically grown tissue tubes, and 
the 19-day statically grown tissue tube.  Using a built-in camera and the Leica image acquisition software 
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to control image parameters such as exposure, pictures were taken of each sample at 4X, 10X, and 20X 
magnification. H&E stained slides were viewed under bright field microscopy while the smooth muscle 
alpha actin and Hoechst stains were viewed under fluorescent microscopy. The Hoechst and smooth 
muscle alpha actin stained samples were merged using ImageJ software. 
6.5 Final Design Testing Results 
6.5.1 Laminar Flow Test Results 
 When the colored water was introduced into the tubing during the first laminar flow test, layers of 
the food coloring and clear water could be seen, as shown in Figure 36.  These layers of color continued 
to be visible until the food coloring ran out. 
 
Figure 36: The silicone tubing is sutured (A) to the syringe needles (B). The red food coloring makes a visible, distinct 
layer (C) above the clear water (D). 
 
 The second laminar flow test attempted to show flow patterns by injecting dye into a flowing 
stream of water. This test provided a variety of results. Some flow patterns appeared to be more laminar, 
as seen in Figure 37A, while others appeared to be more turbulent, as seen in Figure 37B. The images in 
Figure 37A demonstrate straight paths of dye and little mixing. Figure 37B shows mixing and swirling of 
the dye. The dye is also seen flowing backward. While this test showed the possibility of both laminar 
and turbulent flow, there were several variables which may have affected the flow and will be presented 
in the discussion chapter. 
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Figure 37: Flow patterns that resembled laminar flow (A) and turbulent flow (B). 
  
 A third laminar flow test was performed in order to eliminate the effect of the needle’s presence 
on the flow of the water. Dye was injected upstream of the Luer connectors. No turbulent flow was 
observed. Figure 38 shows flow profiles for the laminar flow testing. 
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Figure 38: Laminar flow shown by upstream injection of food coloring. This image shows a thin stream (A) as well as a 
thick steam (B) showing no signs of turbulent flow. 
6.5.2 Sterility assessment Results 
Sterility assessments were performed in order to determine if our device could run in an incubator 
for a certain period of time and remain sterile. Evaporation was observed after the first sterility 
assessment as seen in Figure 39. The cell media evaporated leaving the inlet Luer exposed to air. The 
outlet Luer was also not fully submerged. The evaporation was most likely caused by a lack of water in 
the incubator which may have affected the humidity. A second test needed to be run with the proper 
humidity in the incubator. 
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Figure 39: The cell media evaporated which did not allow the cell media to contact the inlet Luer (A). The cell media just 
barely reached the outlet Luer (B). The level of media is indicated by an arrow in the side-view. 
 
 No turbidity was seen in the media after the first sterility assessment. However, some small 
particles were observed. The contents of the bioreactor were emptied into a tissue culture flask and 
examined under a microscope with Trypan Blue stain. Everything in the flask stained blue, which 
indicated that no living organisms were in the media. It was concluded that the particles may have been 
plastic shavings from when the chamber was being sanded. 
A second sterility assessment was performed after distilled water was poured into the water pan 
of the incubator. After the first day, there was a small amount of leakage in the tray around the bioreactor, 
seen in Figure 40. When this was observed, it was discovered that somehow the pump had been activated 
incorrectly and was running in reverse. No media was replaced or added to the bioreactor chamber. The 
leak was cleaned up and the pump was set to run forward for another day.  
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Figure 40: The leakage observed in the tray occurred after 1 day in the incubator. 
 
 When the bioreactor was removed on the second day, minor leakage was observed but could have 
been residue underneath the chamber from the previous day’s leakage. Figure 41 shows the level of media 
present in the chamber after two days and after the leakage on day one. The media level was at the center 
of the inlet Luer. There may have been a small amount of evaporation, but the loss of media is mainly due 
to the leakage on day one. It was also observed that the media remained the same in color, indicating 
there was no major contamination present. 
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Figure 41: After two days in the incubator and a minor leak, the remaining media in the bioreactor filled the chamber to 
about the middle of the inlet Luer (A). 
 
 Finally, after two days in the incubator, the media was removed from the bioreactor and put into a 
tissue culture flask for further examination. No turbidity was observed in the media, indicating a lack of 
contaminants as seen in Figure 42. The contents of the flask were viewed under a microscope and a few 
particles were seen. None of the particles were moving or appeared to be bacteria. It was concluded that 
no contaminants were found.  
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Figure 42: The cell media after two days in the incubator is shown. No turbidity was observed and the color remained 
unchanged. 
 
A third sterility assessment was performed with fetal bovine serum in our media. The rat carotid 
arteries were unable to be mounted on the syringe tips.  We then had to resort to suturing the 1cm piece 
of 1.47 mm inner diameter silicone tubing onto the syringe tips.  At the 24hour mark the media had 
changed to an orange color and turbidity was observed, as seen in Figure 43.  This was indicative of 
contamination and we confirmed this by observing the media under a microscope, as seen in Figure 44.  
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Figure 43: After 24 hours, the cell media had turned orange and was turbid. 
 
 
Figure 44: Media sample of Sterility assessment 3 as seen under microscope. The media appeared to contain bacteria. 
6.5.3 Leakage Test Results 
 During the first leakage test, we noticed leaking between the inlet Luer connector and the 
stationary arm Luer connector.  The second leakage test we performed focused on leaking that would 
occur between the tissue tube and the blunt-end needles.  To do this, we sutured a 1.47mm inner diameter 
silicone tube onto the needles and ran water through the flow loop.  Either due to our relative 
inexperience with suturing or because of the tube’s resilience and thickness, there was almost always 
leaking from this area occurring when we had the pump turned on. We resolved the leaking problems, as 
discussed later in the discussion section. 
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6.5.4 Volume Test Results 
 The amount of water that the chamber could contain without spilling out the back ridge slots 
when the lid was locked in place was found to be 26mL. 
6.5.5 Histological Analysis Results 
At the 24 and 48 hour marks, we checked on the bioreactor and the fixed tissue tube.  The media in the 
wells of the static cultures had turned slightly orange but was not turbid or cloudy.  The media in the 
bioreactor was pink and flowing through the system correctly. Each day more distilled water was added to 
the incubator to maintain humidity.  Unfortunately, at the 72 hour mark we noticed that there was very 
little media in the tubing and the bioreactor while the pump was still running.   
 
Figure 45: At 72 hours, no media was flowing through the system and a puddle of media was found (A). 
 When the bioreactor sample was taken out of the incubator, the tissue appeared more opaque and 
thicker than when it was first mounted to the bioreactor. The physical difference after 3 days in dynamic 
culture can be seen in Figure 46.  
 
Figure 46: The tissue tube mounted at day 19 (A) and the tissue tube after 3 days of dynamic culture (B). 
H&E staining enabled us to compare the 19-day old statically cultured tissue tube (Figure 47) the 
22-day statically cultured tissue tube (Figure 48) to the 22-day bioreactor cultured tissue tube (Figure 49). 
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This stain showed a significant increase in wall thickness of both 22-day tissue tubes.    Formation of 
two layers can clearly be seen in both 22-day samples, whereas the cellular structure appears more 
uniform in the 19-day tissue tube. 
  
Figure 47: Cross section of 19-day tissue (H&E staining at 4x magnification). 
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Figure 48: Cross section of 22-day statically grown tube (H&E staining at 4x magnification) 
 
 
Figure 49: Cross section of the 22-day bioreactor tissue (H&E staining at 4x magnification).  Distinct inner and outer 
layers can be seen.  
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Significant amounts of fragmented nuclei were visible in the 22-day statically grown sample 
(Figure 52).  No fragmented nuclei were visible in either the 19-day tissue tube (Figure 50) or the 22-day 
bioreactor tissue tube (Figure 51). Both 22-day tissue tubes exhibited different cell densities. However, 
the 22-day bioreactor tissue tube has a much more noticeable contrast in cell density than the statically 
cultured tissue tube. The darker regions of the images represent a higher cell density.    
 
Figure 50:  Close-up of 19-day statically grown tissue wall (20x magnification). 
 
 
Figure 51: Close-up of 22-day bioreactor tissue tube wall (20x magnification).  Details of the two layers can be seen. No 
fragmented nuclei are present. 
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Figure 52: Close up of 22-day statically grown tissue tube wall (20x magnification).  Distinct layers can be noted by 
change in cellular density. Fragmented nuclei can also be observed.  Examples of fragmented nuclei are circled. 
 
 The Hoechst and smooth muscle alpha actin stains show the nuclei in blue and the actin in green. 
A high presence of alpha actin suggests that a sample has a contractile phenotype, while a sample with 
low actin shows a synthetic phenotype. In order to visualize a known contractile phenotype, a rat aorta 
was stained as the control (Figure 53). Negative controls of each sample were also taken to take factors 
such as auto-fluorescence into consideration (Figure 54).  
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Figure 53: The rat artery acted as the control to show high levels of actin (green). Nuclei are also seen (blue) at 20x 
magnification. 
 
Figure 54: An example of a negative control. The signals are not as strong in the negative control of the rat artery. 
The Hoechst stain, like the H&E stain, revealed that the 22-day statically cultured sample was the 
only sample to exhibit a significant amount of fragmented nuclei, as seen in Figure 57. Both the 19-day 
sample and the 22-day bioreactor sample lacked fragmented nuclei, as seen in Figure 55 and Figure 56, 
respectively. The smooth muscle alpha actin stain revealed that very low levels of actin were present in all 
three samples. The bioreactor sample showed the least actin, as seen in Figure 56. Both static cultures 
(day 19 and 22) exhibited similar levels of actin. 
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Figure 55: Hoechst and smooth muscle alpha actin stained 19-day sample. Little actin is present (green). No fragmented 
nuclei observed. 
 
Figure 56: Hoechst and smooth muscle alpha actin stained 22-day dynamic (bioreactor) sample. Little to no actin is 
present. No fragmented nuclei were observed. 
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Figure 57: Hoechst and smooth muscle alpha actin stained 22-day static sample. Little actin is present. A few examples of 
fragmented nuclei are outlined in red. 
6.6 Discussion 
6.6.1 Laminar Flow Testing 
 At first glance, the first laminar flow test was believed to show that laminar flow was present, 
based on the distinct layers of fluid observed. However, the dye may be floating on top of the water due to 
the difference in density. We also hypothesized that the layers may have formed because the lower 
portion of fluid in the tube is not moving. If the lower region is not moving, then the clear water would be 
stagnant and the food coloring would flow on top of it. Thus, the next laminar flow test was required. 
 The second laminar flow test was performed due to discrepancies in the previous test. The idea 
behind this test was to see if a stream of dye was disrupted when introduced into the flow of the 
bioreactor. The test showed turbulent flow but there were some factors that could have contributed to 
these results. The injection of the dye was done by hand, and therefore it was difficult to keep the needle 
steady and at a constant height as well as keep constant flow of the dye by pushing down the plunger of 
the syringe. Additionally, the peristaltic pump creates a pulsatile flow, which may contribute to the dye 
swirling backwards. The flow may have also been affected by the presence of the needle in the stream of 
water. It is likely that the needle caused turbulence by blocking and redirecting water flow. In conclusion, 
81 
 
 
 
while turbulent flow was observed, this test is inconclusive due to factors that could not be controlled. 
However, our calculations show that the flow in our device should be laminar because the Reynolds 
Number is well below 2100, as seen inTable2. 
 A third laminar flow test was performed to address the limitations of the second test, namely the 
disruption of fluid flow by the needle. Although the food coloring was injected from a distance away from 
the sutured tubing where it was being observed, the fluid layers were not disturbed and mixing did not 
occur.  The stream of food coloring remains independent of the clear water, which indicates laminar 
flow. 
6.6.2 Sterility Assessing 
In the first sterility assessment we observed several particles.  By using the Trypan Blue stain, 
we were able to conclude that the particles were not alive and were probably just dust and polycarbonate 
shavings from the sanding process.  When we removed the bioreactor from the incubator, nearly all the 
media had disappeared as seen in Figure 39.  We hypothesized two possible reasons why so much media 
was lost.  Either the incubator was poorly saturated with water vapor and evaporation occurred, or there 
was leakage at some area of the chamber.  After emptying all the media out into a cell culture flask we 
filled the chamber with water, ran the pump, and noticed leaking from the outlet Luer connector.  During 
the leakage tests previously conducted we did not notice any leaking at the outlet Luer.  This is probably 
because prior to this test we had unscrewed the outlet Luer connector several times, weakening the Teflon 
tape.  We added a new piece of Teflon tape to the outlet Luer connector and made sure it would not leak 
for the next tests.  This test was not a good representation of the real incubation setup because the pump 
was not used during the incubation. 
The second sterility assessment was performed to address the problems discovered in the first 
test.  This time the pump was included and a silicone tube was used to simulate the tissue tube.  This test 
ran smoothly and no contamination was observed.  After 24 hours, we checked on the bioreactor and 
realized we had accidentally set the pump to run in reverse.  The pump direction should not have had any 
effect on the sterility of the bioreactor.  We also noticed a small puddle of media under the bioreactor.  
Because we made sure the water pan was filled and that the chamber did not leak, we concluded that the 
media spill was from condensation which may have dripped down the side of the chamber. 
After the second sterility assessment we realized two problems that had occurred due to the 
autoclave process.   The first problem we noticed was that the magnet was rusting.  Also, the steel piece 
embedded in the lid protruding out of the lid.  The magnet used in our bioreactor was nickel plated.  
Nickel plating is supposed to prevent the magnet from rusting, but it appeared the plating had begun to 
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chip away, resulting in rust as seen in Figure 58.  An orange ring-shaped stain had developed on the 
magnetic track where the magnetic arm usually rested.  This stain was likely due to the rust of the 
magnet or from melting epoxy.  With regards to the steel, the epoxy used to keep it in place, which was 
the same used on the magnet, had melted and re-solidified, allowing the steel to move slightly each time it 
was autoclaved.  We reattached the original steel and a new magnet in their respective spots with medical 
silicone glue. We decided to use silicone glue because it can withstand the high temperatures of the 
autoclave. 
 
Figure 58: Magnet after it was removed from the movable arm.  The nickel appears to be chipped causing it to rust. 
 
 Unfortunately, the bioreactor did not pass the third sterility assessment.  It was the first time we 
had used fetal bovine serum that provides a nutrient rich environment that promotes proliferation of cells 
and microorganisms.  In the previous two sterility assessments we used only DMEM, which decreases 
the risk of contamination because there are far less nutrients for bacteria to consume. Upon observing the 
bioreactor at the 24hour mark, we noticed the media had changed to a turbid orange color as seen in 
Figure 43.  This was indicative of contamination.  We observed the media under the microscope to 
confirm that it was contaminated as seen in Figure 44. 
 There are several factors that were out of our control and we believe these caused the 
contamination.  The rat arteries were most likely not extracted within a sterile hood and could have been 
contaminated.  Additionally, when we received the rat arteries they had not been washed with antibiotics.  
Even though we did not successfully mount the rat arteries in the bioreactor, the arteries came in contact 
with the components of the bioreactor during set up. We do not think our bioreactor is unsafe for living 
tissue but believe the rat arteries were not sterile and were responsible for the contamination. 
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6.6.3 Leakage Testing 
 To eliminate leaking around the Luer connectors, we wrapped Teflon tape around the screw 
threads of the Luers.  After screwing them in, we filled the chamber back up to make sure the Teflon tape 
sealed the threading.  No leaking was observed.  If for some reason we have to remove or adjust the 
Luer connectors, there is a potential they may leak again if Teflon tape is not reapplied.  
 After a few attempts, we were able to successfully suture 1.47mm inner diameter silicone tubing 
onto the syringe tips and run the pump without any leaking at the tube-syringe interface. 
6.6.4 Volume Testing 
 The bioreactor chamber has been redesigned to use the least amount of media required to keep a 
tube healthy for a three day period.  The chamber is just big enough to accommodate the locking lid 
mechanism without requiring too much media.  The chamber can hold 26mL, which is a sufficient 
amount of media for three days considering a tissue tube typically uses 6mL per day.   
6.6.5 Histological Analysis 
 While feeding the static culture tissue tubes, the media was slightly orange, but was neither 
cloudy nor turbid. This was due to the cells using up the nutrients and was a sign for us to replenish the 
media.  After 72 hours, we removed the bioreactor and pump and observed that the majority of the media 
was gone from the system.  There was a pink stain on the pump as well as on the shelf in the incubator, 
as seen in Figure 45.  This led us to believe that the tubing around the rotating portion of the pump had 
split.  We removed the tubing and noticed it was really thin and flat.  Upon cleaning the tubing with 
water and bleach, we realized that our assumption was correct and that there was a hole in that portion of 
the tubing.   Because we checked the bioreactor at the forty-eight hour mark we can safely say that the 
system was running correctly for at least forty-eight hours.   
 Histological results revealed a lack of fragmented nuclei in our 22-day bioreactor tissue tube, 
which indicates that our bioreactor was successful in preventing cell death in the inner layers of the tissue 
tube.   Fragmented nuclei were only observed in the 22-day statically cultured tissue tube due to the lack 
of nutrients diffusing into the inner layers of the tissue.  A lack of fragmented nuclei in the 19-day tissue 
tube indicates that the thickness at 19 days is sufficient for nutrient diffusion into the inner layers, while 
the thickness at day 22 is not. 
 The histology also showed unexpected cell growth patterns.  As seen in Figure 51, there are two 
regions of different contrast levels in the 22-day bioreactor sample, signifying two distinct layers.  The 
difference in contrast level and the number of visible nuclei between the two layers signify that the outer 
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layer has greater cell density.  The inner layer of lower cell density was unexpected ingrowth.  A 
possibility is that that the ingrowth was caused by the lack of perfusion after the tubing broke. The tubing 
broke sometime between 48 and 72 hours, but it is unclear how long the tissue tube went without 
perfusion.  Another possibility is that the wall shear stress caused by the perfusion of the media was too 
low, so cells started growing on the lumen.  
 Finally, actin levels showed that all samples were in the synthetic, not contractile, phenotype. The 
rat aorta control (Figure 53) demonstrates the high level of actin (high contrast, bright green) found in 
contractile smooth muscle cells. Both of the static samples contain very low levels of actin and our 
bioreactor sample seemed to contain no actin at all. The cells in all the samples were also very 
proliferative, which is another trait of synthetic smooth muscle cells. The presence of serum and other 
nutrients in the cell media may have contributed to the synthetic phenotype.  
  
85 
 
 
 
Chapter 7: Potential Influences and Concerns of the Final Design 
7.1 Economical Influence 
During our experimentation significant cell growth was noted after three days.  Therefore, our 
bioreactor offers a fast and efficient way to nourish and grow tissue tubes. Due to the lack of 
contamination and necrosis observed in the tissue tubes, tissue samples are not wasted and therefore 
money is saved.  The bioreactor also does not require a great deal of power to run and it does not waste 
cell media.  The use of our bioreactor can benefit researchers that are currently growing tissue tubes.  
Based on the material cost spent making our final design was low, and we stayed well below our budget 
limit.  Use of our device could facilitate growth and usage of tissue in experiments, saving researchers 
time.  If properly used, our device reduces the possibility of damaging tissue samples, which could 
potentially have a positive economic impact on research done with tissue tubes because fewer tissue tubes 
would be wasted. By being able to perfuse liquid through the lumen of tissue tubes, lining the lumen with 
endothelial cells could be possible and is the next step in developing tissue engineered blood vessels to be 
commercialized. 
7.2 Health and Safety Concerns 
Our device is meant to be used with live tissue and cell-culture media. Any safety or health 
concerns involved with tissue culture should be applied to using our device.  To maintain sterility of all 
items involved, a biosafety cabinet needs to be used when mounting tissue tubes in the bioreactor.  The 
biosafety cabinets emit UV light to disinfect the work area while not in use, which can be dangerous to 
the user and to the tissue if the cabinet is used incorrectly.  Proper precautions should also be taken if any 
sharp objects, such as pipettes and needles, are used.  As with all live cultures, the possibility of bacterial 
or fungal contamination exists. One’s health could potentially be affected if exposed to such 
contamination.  To reduce the risk of human exposure, laboratory standards and aseptic technique should 
be adhered to. 
7.3 Environmental Influence 
 Byproducts of the device will not significantly affect the environment. No toxic fumes, pollutants, 
or chemicals are produced when the device is used.  However, certain items involved with the device 
need to be disposed of.  Used gloves and disposable lab instruments will contribute to the overall waste 
produced.  Polycarbonate waste is a byproduct of the manufacturing process.  Also, procedures involved 
with disposal of biological waste will affect the environment.  The incubators, fume hoods, and the 
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peristaltic pump all get their power from electrical outlets. Overall, there is no particularly hazardous 
waste produced from the manufacture or use of our bioreactor.  The device does not produce much waste 
and does not require an exorbitant amount of energy to run. 
7.4 Societal Influence 
 At this point in time, our device does not have a great impact on society because it is used for 
experimental research.   However, the use of our bioreactor would provide an alternate means for 
growing tissue tube samples.  Successful experiments that solve problems in the medical field may use 
our design to grow tissue.  In that case, our design would contribute to the success of the experiment and 
whatever result is produced.   
7.5 Ethical Concerns 
Currently the smooth muscle cells used to create the tissue tubes are extracted from rat specimen. 
The ethical concern with use of animal cells is that the means of extraction generally requires the animal 
to experience some pain and be euthanized.  However, the potential improvement in the ease of the 
surgical procedure and the quality of life of the patients should be weighed against this.  To ensure 
proper animal treatment, IACUC approved procedures were followed when handling and euthanizing the 
rats. 
7.6 Sustainability of the Device 
 A considerable amount of electrical energy is consumed during the manufacturing and use of the 
device.  The device was manufactured using a HAAS Toolroom Mill, which needs to run for over an 
hour to mill the device.  Another consideration to the sustainability of the device includes the energy 
required to incubate the tissue.  Electrical energy and carbon dioxide are required for the incubator.  A 
peristaltic pump needs to run consistently for the length of time that the tissue is being nourished, which 
in our trials was three full days.  All components of the device, as well as tubing and instruments, must 
be autoclaved prior to use. 
7.7 Manufacturability of the Device 
 Manufacturing the device using the machines, materials, and procedures listed is long and 
tedious. The error involved with the HAAS Toolroom Mill is such that the device needs to be touched 
upon manually.  The device required extensive sanding and trimming so that the lid slid properly over 
the chamber.  The need for manual revisits means that manufacturing the device using current methods is 
time-consuming.  Some components of the device, such as the movable arm, were manually created and 
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therefore subject to human error.  Reproducing our device using the same procedures and machines 
would be inefficient.  Making a few changes to our CAD files, particularly making the fit between the lid 
and the chamber less tight, could make the manufacturing process less difficult. 
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Chapter 8: Conclusions and Recommendations 
Due to the prevalence of cardiovascular disease in America, researchers have been investigating 
ways to grow tissue engineered blood vessels to try to improve current treatment.  In order to fabricate 
tissue engineered blood vessels, the physiological environment must be simulated.   This simulation was 
accomplished by our bioreactor.   Our group designed and produced a perfusion bioreactor to nourish 
tissue tubes internally and externally in hopes of advancing the scientific community’s pursuit of tissue 
engineered blood vessels by improving current tissue tube cultivation methods.  To test the functionality 
of the bioreactor, it was run for a three day period with a live tissue tube mounted inside.  After the 
experiment, we compared tissue tubes that were grown in static culture to the tissue tube that was grown 
in our bioreactor.  Through histology, it was found that while a great deal of fragmented nuclei, 
indicating cell death, were found in the statically grown tube, the tube extracted from our bioreactor 
showed no definitive signs of necrosis.  Therefore, our design met all required constraints while fulfilling 
all our objectives with a unique and user-friendly design. 
8.1 Future Recommendations 
8.1.1 Mounting Method and Interchangeability 
 Although we successfully met the project objectives, there are many things we would have liked 
to incorporate or change about our design.  One of our objectives was to make the bioreactor adjustable 
to accommodate different length tissue tubes.  In order to expand upon the adjustability of our device, we 
suggest making the syringe needles interchangeable. By changing the needles, tubes of different 
diameters would be able to be housed in the bioreactor. Also, it would allow for easy detachment of the 
tissue from the bioreactor while remaining on the syringe needles. Currently, 18 gauge hypodermic tubing 
was tapped and glued into the arms.  Syringe needles with a threading would be an ideal solution because 
they can be changed. To make the syringe needles interchangeable, threaded Luer locks could be 
incorporated into both the stationary arm and movable arm. The lid and chamber would need to be 
lengthened to accommodate for both the Luer locks and the length of the syringe needles. 
8.1.2 Chamber Alterations 
 There are several changes we would recommend regarding the chamber.  One of the main 
problems with the chamber is that it is difficult to see through.  It would be beneficial to the user if they 
could observe the tissue tubes while they are growing without having to take apart the device.  We would 
suggest using a more translucent material which could be autoclaved.  Another alteration we would 
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suggest is to position the chamber’s inlet Luer deeper and make both arms longer so that ultimately the 
tissue tube is suspended deeper within the chamber. By making this alteration, the risk of spilling media 
out of the grooves would be reduced. 
 Due to a miscalculation of the distance between the stationary arm Luer connector and the inlet 
Luer connector, the stationary arm Luer connector had to be sanded down to fit inside the inlet Luer 
connector.  Although this did not interfere with the functionality of the design, it would be better if the 
user did not have to alter the Luer connector length before use.  We would suggest making the chamber a 
quarter inch longer to ensure that the Luer connector will fit correctly.  APPENDIX C: Fixed Future 
Final Design CAD Drawings presents the Final CAD with this change taken into consideration. Along 
with extending the chamber length, we would recommend reducing the chamber thickness.  When the 
device components were finished, it was discovered that there was a great deal of friction when trying to 
remove the lid from the chamber.  We had to sand the lid and chamber down so it did not take as much 
force to attach and detach the lid from the chamber.  By altering the thickness, there will be less friction 
between the lid and chamber. 
8.1.3 Lid Alterations 
 During the machining process, it was brought to our attention that the drill bit needed to drill the 
threaded hole for the Luer connector in the stationary arm could not clear the underside of the lid.  Thus, 
part of the lid had to be bored out in order for the drill bit to make a straight hole through the stationary 
arm. The indent is shown in Figure 59.  This actually worked to our advantage and supplies sufficient gas 
exchange. The earlier suggestion of making the lid deeper would solve the problem as long as the arms 
were extended as well.  However, we suggest a similar shape, albeit smaller, be cut into the lid regardless 
to promote gas exchange. 
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Figure 59: Top picture: Arc cutout on the lid around the inlet Luer connector. 
Bottom Picture: Arc depression in the lid. 
 
 Our device has been autoclaved several times since we changed the epoxy to the silicone glue.  
Unfortunately, we noticed that the steel piece is starting to rust.  So far, the magnet seems unchanged but 
repeated exposure during the autoclave process might affect the silicone glue even more.  Perhaps 
another epoxy such as Loctite® M-121HP would work better.  Another alteration we would suggest is 
making the steel piece a half an inch longer so the movable arm can move back even further allowing 
more room between syringe tips.  
8.1.4 Multiple chambers 
 If we had had more time and funds for our project, we would have undoubtedly produced a 
multiple chamber design for the cultivation of multiple tissue tubes.  This could also be achieved by 
simply using multiple bioreactors hooked up to a multichannel peristaltic pump. 
8.1.5 Endothelialization 
 Although it was not in the scope of our project, we would suggest using our bioreactor to 
endothelialize the tissue tubes. The bioreactor's flow is laminar and should work well in this application.  
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By lining the tissue tubes with endothelial cells, the tissue tube will be one step closer to mimicking an 
artery.  
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APPENDIX A: Testing Protocols 
Total Chamber Volume Test 
1. Block the inlet and outlet by attaching silicone tubing and tying it off. 
2. Fill the chamber with water until it reaches the two cut outs for the track lips. 
3. Place the lid on the chamber so that any excess squeezes out and make sure water is covering the 
syringe needles. 
4. Remove the lid and empty the chamber contents into a graduated cylinder for measuring.  
Flow Rate Test Protocol 
1. Insert the 3/16‖ tubing that came with the Fischer Science pump into the peristaltic pump (0.4-85 
mL/min) and attach to 1/16‖ tubing. 
2. Connect 1/16‖ tubing to the barb of the outlet of the bioreactor chamber. 
3. Plug the inlet so that it is sealed. 
4. Put the end of the 1/16‖ tubing into a graduated cylinder. 
5. Fill the chamber with water and run the pump so that the water is flowing from the chamber to 
the graduated cylinder. 
6. Once the fluid starts to drip into the cylinder, being timing for 3 minutes. 
7. After 3 minutes, stop the pump and measure the volume. Divide the volume by three to get a flow 
rate of mL/minute.  
8. Repeat for various pump settings.  
Closed Flow Loop Testing Protocol (Suture Leakage) 
1. Suture tubing or tissue tube into place on syringe needles. 
2. Fill chamber with dyed water/media. 
3. Attach lid to the chamber and the tubing to the appropriate inlets/outlets. 
4. Begin the pump and allow all air bubbles to be released. 
5. Turn off the pump and remove the lid. 
6. The colored liquid should still remain in the tube. Dry off any excess to check for leaking.  
Stationary Arm Leakage Testing Protocol 
1. Remove the lid from the bioreactor and lay it flat on the bench top. 
2. Prepare stained water by mixing water and food coloring in a glass. 
3. Pipette the colored water through the Luer on the stationary arm until water comes out of syringe 
needle. 
4. If colored water is found at any other point except the end of the syringe needle, there is leakage.  
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Laminar Flow Test (AcrylicPrototype)Protocol 
1. Lay the bioreactor lid on the bench top. 
2. Suture 1.47mm ID silicone tubing onto syringe needles. 
3. Set up high resolution video recorder about 1 inch away from the silicone tubing. 
4. Attach female Luer to the male Luer on stationary arm. 
5. Attach tubing from the barb of the female Luer, which was just attached, to the ―out‖ port of the 
pump. 
6. Fill beaker with water and add particles (colored sugar bits). 
7. Put the end of another piece of tubing into the clear water and attach the other end to the ―in‖ port 
of the pump. 
8. Start the video recorder. 
9. Run the pump on 2 (slow). 
10. Observe movement patterns of particles flowing through the clear tubing to determine if 
turbulence is present.  
Laminar Flow Test 1 Protocol 
1. Lay the bioreactor lid on the bench top. 
2. Suture 1.47mm ID silicone tubing onto syringe needles. 
3. Set up high resolution camcorder about 1 inch away from the silicone tubing. 
4. Attach female Luer to the male Luer on stationary arm. 
5. Attach tubing from the barb of the female Luer, which was just attached, to the ―out‖ port of the 
pump. 
6. Fill beaker with water. 
7. Put the end of another piece of tubing into the clear water and attach the other end to the ―in‖ port 
of the pump. 
8. Run the pump on 1 (fast) to fill tubing with clear water. 
9. Put colored water, dyed with food coloring, into a pipette and pick the tubing out of the water.  
10. Insert the pipette into the tube and squeeze the colored water into the tubing. 
11. Run the pump again and use the camcorder to capture the colored water passing through the 
sutured tubing. 
12. Observe how the water and food coloring react in the clear tubing.  Look for straight lines and 
layers. 
Laminar Flow Test 2 Protocol 
1. Lay the bioreactor lid on the bench top. 
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2. Suture 1.47mm ID silicone tubing onto syringe needles. 
3. Set up high resolution camcorder about 1 inch away from the silicone tubing. 
4. Put several drops of food coloring into syringe and attach 30 gauge needle. 
5. Attach female Luer to the male Luer on stationary arm. 
6. Attach tubing from the barb of the female Luer, which was just attached, to the ―out‖ port of the 
pump. 
7. Fill beaker with water. 
8. Put the end of another piece of tubing into the clear water and attach the other end to the ―in‖ port 
of the pump. 
9. Turn on the camcorder to record. 
10. Run the pump on 1 (fast) to fill tubing with clear water. 
11. Use the needle to poke through the sutured silicone tubing near the inlet blunt end syringe needle 
and inject the food coloring slowly. 
12. Observe how the water and food coloring react in the clear tubing.  Look for straight lines and 
layers. 
Laminar Flow Test 3 Protocol 
1. Lay the bioreactor lid on the bench top. 
2. Suture 1.47mm ID silicone tubing onto syringe needles. 
3. Set up high resolution camcorder about 1 inch away from the silicone tubing. 
4. Put several drops of food coloring into syringe and attach 30 gauge needle. 
5. Attach female Luer to the male Luer on stationary arm. 
6. Attach tubing from the barb of the female Luer, which was just attached, to the ―out‖ port of the 
pump. 
7. Fill beaker with water. 
8. Put the end of another piece of tubing into the clear water and attach the other end to the ―in‖ port 
of the pump. 
9. Turn on the camcorder to record. 
10. Run the pump on 1 (fast) to fill tubing with clear water. 
11. Use the needle to poke through the silicone tubing connecting the pump to the inlet Luer of the lid 
near the inlet Luer. Inject the food coloring slowly. 
12. Observe how the water and food coloring react in the clear tubing.  Look for straight lines and 
layers. 
Sterility assessment 1 Protocol 
99 
 
 
 
1. Autoclave bioreactor for 20 minutes in autoclavable disposable bag. 
2. Remove from autoclave and place into clean laminar flow hood. 
3. Open the bag in the hood and remove the sterile bioreactor. Remove the lid. 
4. Using a pipette, put 26mL of DMEM (cell media without antibiotics) into chamber of bioreactor.  
5. Replace lid and put the bioreactor in the incubator for 2 nights.  
Sterility assessment 2 Protocol 
1. Autoclave bioreactor and silicone tubing for 20 minutes in autoclavable disposable bag(s). 
2. Remove bag(s) from autoclave and place into clean laminar flow hood. 
3. Open the bag(s) in the hood and remove the sterile bioreactor and tubing. Remove the lid of the 
bioreactor and set aside. 
4. Wipe the surfaces of the peristaltic pump with 70% ethanol and place in hood. 
5. Attach 1/16‖ silicone tubing to the pump. Attach the pump outlet to the inlet of the chamber and 
put the tubing from the pump inlet into a clean beaker. 
6. Using a pipette, dispense about 26mL of DMEM into the beaker from step 5.  
7. Run the pump forward until the chamber and tubing are filled with media. Dispense more media 
into the beaker if necessary. When full, lock lid in place. 
8. Move bioreactor and peristaltic pump into an incubator on a tray to contain any spills. Thread the 
power cord for the pump through the port in the back of the incubator and plug into power strip. 
9. Run pump forward on the 1 Fast setting for ~48 hours. 
Sterility assessment 3 Protocol 
1. Autoclave bioreactor and silicone tubing for 20 minutes in autoclavable disposable bag(s). 
2. Remove bag(s) from autoclave and place into clean laminar flow hood. 
3. Open the bag(s) in the hood and remove the sterile bioreactor and tubing. Remove the lid of the 
bioreactor and set aside. 
4. Wipe the surfaces of the peristaltic pump with 70% ethanol and place in hood. 
5. Attach 1/16‖ silicone tubing to the pump. Attach the pump outlet to the inlet of the chamber and 
put the tubing from the pump inlet into a clean beaker. 
6. Using a pipette, dispense 27mL of DMEM and 3mL of FBS into the beaker from step 5.  
7. Run the pump forward until the chamber and tubing are filled with media. When full, lock lid in 
place. 
8. Move bioreactor and peristaltic pump into an incubator on a tray to contain any spills. Thread the 
power cord for the pump through the port in the back of the incubator and plug into power strip. 
9. Run pump forward on the 1 Fast setting for ~48 hours. 
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Connection Leakage Test Protocol 
1. Suture silicone tubing to the syringe needle on the stationary arm. 
2. Snake the silicone tubing through the outlet Luer of the chamber. 
3. Attach silicone tubing from peristaltic pump inlet to a container of water. 
4. Attach silicone tubing from peristaltic pump outlet to the inlet of the stationary arm. 
5. Connect the lid and chamber and run the pump. If water flows out of the tubing, the connection 
between the chamber and the lid has been made. If water accumulates in the chamber, the Luers 
are not connected.  
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APPENDIX B: Final Design CAD Drawings 
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APPENDIX C: Fixed Future Final Design CAD Drawings 
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